Processing 00000000.tx.1: Substitution of a Glycogen Synthase Kinase-3 Phosphorylation Site in Presenilin 1Separates Presenilin Function from -Catenin Signaling* Ford Kirschenbaum, Shu-Chi Hsu, Barbara Cordell, and Justin V. 

Phrase: "Substitution of a Glycogen Synthase Kinase-3 Phosphorylation Site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1555721:Substitution [Idea or Concept]
   742   C1706204:Substitution [Activity]

Phrase: "in Presenilin 1Separates Presenilin Function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "from -Catenin Signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "* Ford Kirschenbaum,"

Phrase: "Shu-Chi Hsu,"

Phrase: "Barbara Cordell,"

Phrase: "and"

Phrase: "Justin V."
Processing 00000000.tx.2: McCarthy From Scios Inc., Sunnyvale, California 94086 Received for publication, May 31,2000, and in revised form, November 27,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The majority of cases with early onset familial Alzheimer's disease have been attributed to mutations in the presenilin 1(PS1) gene. 

Phrase: "McCarthy From Scios Inc.,"

Phrase: "Sunnyvale,"

Phrase: "California 94086"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "May 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "November 27,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The majority of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "with early onset familial Alzheimer's disease"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "in the presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.3: PS1 protein is a component of a high molecular weight membrane-bound complex that also contains -catenin. 

Phrase: "PS1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a component of a high molecular weight membrane-bound complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0449432:Component [Manufactured Object]
   739   C1705248:Component [Conceptual Entity]

Phrase: "that also"

Phrase: "contains -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "catenin."
Processing 00000000.tx.4: The physiological relevance of the association between PS1 and -catenin remains controversial. 

Phrase: "The physiological relevance of the association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "remains"

Phrase: "controversial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]
Processing 00000000.tx.5: In this study, we report the identification and functional characterization of a highly conserved glycogen synthase kinase-3 consensus phosphorylation site within the hydrophilic loop domain of PS1. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "functional characterization of a highly conserved glycogen synthase kinase-3 consensus phosphorylation site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1880022:Characterization [Activity]

Phrase: "within the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.6: Site-directed mutagenesis, together with in vitro and in vivo phosphorylation assays, indicates that PS1 residues Ser353 and Ser357 are glycogen synthase kinase-3 targets. 

Phrase: "Site-directed mutagenesis,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "together with in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo phosphorylation assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "indicates"

Phrase: "that PS1 residues Ser353"

Phrase: "and"

Phrase: "Ser357"

Phrase: "are"

Phrase: "glycogen synthase kinase-3 targets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1521840:Target [Functional Concept]
   771   C2986546:TARGET [Diagnostic Procedure]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.7: Substitution of one or both of these residues greatly reduces the ability of PS1 to associate with -catenin. 

Phrase: "Substitution of one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "or"

Phrase: "both of these residues greatly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "reduces"

Phrase: "the ability of PS1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "associate with -catenin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.8: By disrupting this interaction, we demonstrate that the association between PS1 and -catenin has no effect on A peptide production, -catenin stability, or cellular susceptibility to apoptosis. 

Phrase: "By disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "this interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin"

Phrase: "has"

Phrase: "no effect on A peptide production, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "catenin stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "or"

Phrase: "cellular susceptibility to apoptosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C1413749:CELLULAR APOPTOSIS SUSCEPTIBILITY [Gene or Genome]
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.9: Significantly, in the absence of PS1/-catenin association, we found no alteration in -catenin signaling using induction of this pathway by exogenous expression of Wnt-1 or -catenin and a Tcf/Lef transcriptional assay. 

Phrase: "Significantly,"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of PS1/-catenin association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no alteration in -catenin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "induction of this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by exogenous expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Wnt-1 or -catenin"

Phrase: "and"

Phrase: "a Tcf/Lef transcriptional assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.10: These results argue against a pathologically relevant role for the association between PS1 and -catenin in familial Alzheimer's disease.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "argue against a pathologically relevant role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "for the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin in familial Alzheimer's disease."
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The familial form of Alzheimer's disease (FAD)1 has been found to be largely attributed to mutations in the presenilin proteins, presenilin 1(PS1) and presenilin 2(PS2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The familial form of Alzheimer's disease (FAD)1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely"

Phrase: "attributed to mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "in the presenilin proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS2"

Phrase: ")."
Processing 00000000.tx.12: The role of PS proteins in Alzheimer's disease is of interest because of the strong causal relationship to the disease (reviewed in Ref. 1). 

Phrase: "The role of PS proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0543488:Interest [Mental Process]

Phrase: "because of the strong causal relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439849:Relationship [Qualitative Concept]
   827   C1705630:Relationship [Idea or Concept]
   827   C1706279:Relationship [Idea or Concept]
   827   C3540605:Relationship [Intellectual Product]

Phrase: "to the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.13: The mechanism(s) through which FAD PS leads to Alzheimer's pathogenesis is not clearly defined, although recent advances have been made regarding PS structure and function. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) through which FAD PS"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   784   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   764   C1832428:Familial form [Finding]
   762   C0277558:Familial disease [Disease or Syndrome]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0241888:Familial [Functional Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1418867:Ps [Gene or Genome]
   742   C1518860:PS [Geographic Area]
   742   C1522492:Form [Functional Concept]
   742   C1552158:Ps [Body Part, Organ, or Organ Component]
   742   C2603362:S' [Clinical Attribute]
   726 E C0344339:disease family [Finding]

Phrase: "leads to Alzheimer's pathogenesis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "although"

Phrase: "recent advances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0725066:Advance [Medical Device]

Phrase: "have"

Phrase: "been"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "regarding"

Phrase: "PS structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.14: PS are polytopic membrane proteins to which a variety of functions have been linked including protein processing and transport, as well as for intracellular signaling in cell fate determination, survival, apoptosis, and response to stress (reviewed in Refs. 2-4). 

Phrase: "PS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418867:Ps [Gene or Genome]
  1000   C1518860:PS [Geographic Area]
  1000   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "polytopic membrane proteins to which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "a variety of functions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033666:protein processing [Molecular Function]
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "as well as for intracellular signaling in cell fate determination,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C1160037:cell fate determination [Cell Function]
   760   C1540661:cell fate [Cell Function]
   757   C0037083:Cell Signaling [Cell Function]
           Signaling
   739   C0007634:Cell [Cell]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0205170:Well [Qualitative Concept]
   739   C1148554:determination [Laboratory Procedure]
   739   C1269647:Cell [Cell]
   739   C1539479:FATE [Gene or Genome]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C3146287:Well [Manufactured Object]
   739   C3537152:signaling [Biologic Function]

Phrase: "survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "response to stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0149784:response to stress [Physiologic Function]
           response stress
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "("

Phrase: "reviewed in Refs. 2-4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0282443:reviewed [Intellectual Product]
   760   C1425988:REF [Gene or Genome]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.15: Association between PS1 and a number of proteins, including -catenin (5-7), has been reported. 

Phrase: "Association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "a number of proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "catenin"

Phrase: "(5-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.16: Both PS1 and -catenin have been identified as components of a high molecular weight membrane complex present in the endoplasmic reticulum and Golgi apparatus (8). 

Phrase: "Both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "have"

Phrase: "been"

Phrase: "identified as components of a high molecular weight membrane complex present"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   775   C1979900:High molecular weight [Qualitative Concept]
   756   C0026385:Molecular Weight [Quantitative Concept]
   754   C0948775:high weight [Sign or Symptom]
   738   C0005910:weight [Organism Attribute]
   738   C0025255:Membrane [Tissue]
   738   C0043100:Weight [Quantitative Concept]
   738   C0150312:Present [Quantitative Concept]
   738   C0205250:High [Qualitative Concept]
   738   C0205396:Identified [Qualitative Concept]
   738   C0439855:Complex [Qualitative Concept]
   738   C0449432:Components [Manufactured Object]
   738   C0449450:Present [Idea or Concept]
   738   C0596901:Membrane [Cell Component]
   738   C1299351:High [Qualitative Concept]
   738   C1305866:weight [Diagnostic Procedure]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1550043:Identified [Finding]
   738   C1551388:Identified [Functional Concept]
   738   C1704241:Complex [Chemical Viewed Structurally]
   738   C1705104:Weight [Idea or Concept]
   738   C1706182:Membrane [Manufactured Object]
   738   C2700149:HIGH [Intellectual Product]
   704 E C1705248:Component [Conceptual Entity]

Phrase: "in the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi apparatus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.17: The large hydrophilic loop located between transmembrane domains 6and 7of the 8transmembrane PS1 contains the domain(s) responsible for -catenin binding (7, 9, 10). 

Phrase: "The large hydrophilic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "located between transmembrane domains 6and 7of"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1519623:Transmembrane Domain [Amino Acid Sequence]
   753   C1167322:transmembrane [Cell Component]
   753   C2752508:transmembrane [Cell Component]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "the 8transmembrane PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "s)"

Phrase: "responsible for -catenin binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "(7,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.18: Furthermore, glycogen synthase kinase-3 (GSK-3), the serine/threonine kinase that regulates -catenin levels, has also been shown to associate with PS1 (11). 

Phrase: "Furthermore,"

Phrase: "glycogen synthase kinase-3 (GSK-3),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the serine/threonine kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
  1000   C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "regulates -"

Phrase: "catenin levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0750490:Associate [Idea or Concept]
   790   C1418985:PS1 [Gene or Genome]
   790   C1706221:Associate [Professional or Occupational Group]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.19: The regulation of cytoplasmic -catenin levels is pivotal to the Wnt signal transduction pathway. 

Phrase: "The regulation of cytoplasmic -catenin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "pivotal to the Wnt signal transduction pathway."
Processing 00000000.tx.20: Wnt signaling regulates cell fate determination during development and cell proliferation in adult tissues (reviewed in Ref. 12). 

Phrase: "Wnt signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2984359:Wnt signaling [Functional Concept]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "regulates"

Phrase: "cell fate determination during development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C1160037:cell fate determination [Cell Function]
   760   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "cell proliferation in adult tissues"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0596290:Cell Proliferation [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1514485:Proliferation [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "reviewed in Ref. 12"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.21: In the absence of Wnt signal, no signal transduction occurs due to the rapid degradation of -catenin. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Wnt signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "no signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "occurs due to the rapid degradation of -catenin."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0243125:degradation [Functional Concept]
   744   C0439831:Rapid [Qualitative Concept]
   744   C0699900:Degradation [Organism Function]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   744   C3146286:Due [Idea or Concept]
Processing 00000000.tx.22: -Catenin is targeted for ubiquitination and proteosome degradation following phosphorylation by GSK-3. 

Phrase: "-Catenin"

Phrase: "is"

Phrase: "targeted for ubiquitination"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1519751:Ubiquitination [Molecular Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "proteosome degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "phosphorylation by GSK-3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.23: The activity of the -catenin complex is regulated by other proteins present, such as Axin and adenomatous polyposis coli (APC), which facilitate the phosphorylation of -catenin by GSK-3. 

Phrase: "The activity of the -catenin complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "regulated by other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: ","

Phrase: "such as Axin and adenomatous polyposis coli (APC),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
           Adenomatous polyposis
           Polyposis Coli
   845   C0162832:adenomatous polyposis coli [Gene or Genome]
   795   C0334108:Polyposis [Neoplastic Process]

Phrase: "which"

Phrase: "facilitate"

Phrase: "the phosphorylation of -catenin by GSK-3."
Processing 00000000.tx.24: The ability of Axin and APC to facilitate -catenin phosphorylation is mediated by phosphorylation of both proteins by GSK-3. 

Phrase: "The ability of Axin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "APC to"

Phrase: "facilitate -"

Phrase: "catenin phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "mediated by phosphorylation of both proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.25: Upon stimulation of the Wnt receptor, GSK-3 is inhibited, resulting in an increase in the cytosolic level of -catenin rendering the protein available for transport to the nucleus where it activates Wnt target genes. 

Phrase: "Upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of the Wnt receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414886:Wnt receptor [Gene or Genome]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "resulting in an increase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in the cytosolic level of -catenin rendering"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "available for transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "to the nucleus where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: "it"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Wnt target genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1332838:Target Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.26: PS1 also participates in the regulation of cytoplasmic -catenin levels, although the nature of this modulation is unclear. 

Phrase: "PS1 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "participates in the regulation of cytoplasmic -catenin levels,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0441889:Levels [Qualitative Concept]
   744   C0521449:Cytoplasmic [Body Location or Region]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "although"

Phrase: "the nature of this modulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.27: Many insights regarding the role of PS1 in -catenin regulation have come from comparisons of normal PS1 with those bearing FAD mutations. 

Phrase: "Many insights"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233820:insights [Mental Process]

Phrase: "regarding"

Phrase: "the role of PS1 in -catenin regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "have"

Phrase: "come from comparisons of normal PS1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205307:Normal [Qualitative Concept]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439166:% normal [Quantitative Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2986918:PS1 [Gene or Genome]
   719   C1707455:Comparison [Activity]

Phrase: "with those bearing FAD mutations."
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   846   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   842   C0277558:Familial disease [Disease or Syndrome]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   807   C1832428:Familial form [Finding]
   806 E C0344339:family disease [Finding]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:familial [Family Group]
   791   C0026882:Mutations [Genetic Function]
   791   C0241888:Familial [Functional Concept]
   791   C0332287:With [Qualitative Concept]
   791   C0348078:Form [Qualitative Concept]
   791   C0376315:Form [Manufactured Object]
   791   C1522492:Form [Functional Concept]
   791   C1704689:Bearing [Medical Device]
   791   C1705690:With [Intellectual Product]
   758 E C0004897:Bear [Mammal]
   758 E C1705285:Mutation [Cell or Molecular Dysfunction]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   720 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.28: However, conflicting results have prevented firm conclusions. 

Phrase: "However,"

Phrase: "conflicting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009671:conflicting [Individual Behavior]
   966 E C1705242:Conflict [Qualitative Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "have"

Phrase: "prevented firm conclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707478:Conclusions [Idea or Concept]
Processing 00000000.tx.29: FAD PS1 appears to increase -catenin degradation (13, 14) although contrary results have also been reported (15, 16). 

Phrase: "FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase -"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "catenin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: "although"

Phrase: "contrary results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.30: This loss of -catenin signal in a neuronal background has been linked to increased susceptibility to apoptosis (13). 

Phrase: "This loss of -catenin signal in a neuronal background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2984840:SIGNAL LOSS [Functional Concept]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "linked to increased susceptibility"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C0442805:Increased [Functional Concept]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: FAD PS1 was also shown to compromise the ability of -catenin to translocate to the nucleus, a state that could potentiate apoptosis (16). 

Phrase: "FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "the ability of -catenin to"

Phrase: "translocate to the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "a state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "that"

Phrase: "could"

Phrase: "potentiate"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.32: We have identified three GSK-3 consensus phosphorylation sites in the PS1 hydrophilic loop domain. 

Phrase: "We"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "three GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   793   C0031715:Phosphorylation [Molecular Function]
   793   C0205145:Sites [Spatial Concept]
   793   C1158886:Phosphorylation [Molecular Function]
   779   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760 E C1515974:Site [Body Location or Region]
   760 E C2825164:Site [Spatial Concept]

Phrase: "in the PS1 hydrophilic loop domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.33: Similar to Axin or APC, phosphorylation of PS1 by GSK-3 may serve to regulate -catenin phosphorylation, thereby regulating -catenin/Tcf gene expression. 

Phrase: "Similar to Axin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "APC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate -"

Phrase: "catenin phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "thereby"

Phrase: "regulating -"

Phrase: "catenin/Tcf gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.34: To test this hypothesis, we have characterized the role of each GSK-3 phosphorylation consensus motif in PS1/-catenin association and identified one to be critical.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the role of each GSK-3 phosphorylation consensus motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in PS1/-catenin association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "identified one to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "be"

Phrase: "critical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Cell Culture-- Human embryonic kidney (HEK) 293T cells were grown in DMEM-21 containing 10% fetal bovine serum, 1% L-glutamine, and antibiotics (50units/ml penicillin and 50g/ml streptomycin). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Human embryonic kidney (HEK) 293T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   836   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM-21"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "1% L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "(50units/ml penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "50g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: ")."
Processing 00000000.tx.36: Cells were maintained in a humidified 37C incubator with 5% CO2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in a humidified 37C incubator"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0021178:Incubator [Manufactured Object]
   753   C1314677:Maintained [Functional Concept]
   719 E C0024501:Maintain [Activity]

Phrase: "with 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.37: Transfection was carried out by subconfluent seeding of 293HEK cells into six-well tissue culture plates and transfecting DNA using the calcium phosphate precipitation method. 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by subconfluent seeding of 293HEK cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0007634:Cells [Cell]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1705192:Seeding [Laboratory Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "into six-well tissue culture plates"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   840   C0040284:Tissue culture [Laboratory Procedure]
   840   C0180454:culture plates [Medical Device]
   804   C0010453:Culture [Idea or Concept]
   804   C0040300:Tissue [Tissue]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1139930:plates [Medical Device]
   804   C1547928:Tissue [Intellectual Product]
   804   C2242979:Culture [Laboratory Procedure]
   771 E C0005971:Plate [Medical Device]
   771 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "transfecting DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium phosphate precipitation method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.38: Expression Vector Construction-- A cDNA encoding PS1 was amplified by standard polymerase chain reaction techniques and subcloned into a C-terminal Myc-His6-tagged mammalian expression vector, pcDNA3.1/Myc-His() (Invitrogen). 

Phrase: "Expression Vector Construction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441513:Construction [Therapeutic or Preventive Procedure]
   734   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "-"

Phrase: "-"

Phrase: "A cDNA encoding PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "amplified by standard polymerase chain reaction techniques"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0025664:techniques [Intellectual Product]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C0449851:Techniques [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1442989:Standard [Qualitative Concept]
   748   C1524075:Chain [Idea or Concept]
   748   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "into a C-terminal Myc-His6-tagged mammalian expression vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0442335:Vector [Spatial Concept]
   791   C1705099:Vector [Idea or Concept]

Phrase: "pcDNA3.1/Myc-"

Phrase: "His"

Phrase: "("

Phrase: ")"

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.39: Site-directed mutagenesis of the serine and threonine residues found in PS1, which conform to the aforementioned (S/T)XXXS consensus phosphorylation site were generated by using a two-primer pair method protocol outlined by the QuikChangeTM site-directed mutagenesis kit (Stratagene). 

Phrase: "Site-directed mutagenesis of the serine"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   783   C2945843:Site of [Qualitative Concept]
   753   C0079866:Mutagenesis [Molecular Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   753   C3146302:Mutagenesis [Laboratory Procedure]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "threonine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "found in PS1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0150312:Found [Quantitative Concept]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]
   756 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "conform to the aforementioned"

Phrase: "("

Phrase: "S/"

Phrase: "T)XXXS consensus phosphorylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1519063:Phosphorylation Site [Amino Acid Sequence]
   804   C0031715:Phosphorylation [Molecular Function]
   804   C0205145:Site [Spatial Concept]
   804   C1158886:Phosphorylation [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-primer pair method protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]

Phrase: "outlined by the QuikChangeTM site-directed mutagenesis kit (Stratagene"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   742   C0079866:Mutagenesis [Molecular Function]
   742   C0205145:Site [Spatial Concept]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C2825164:Site [Spatial Concept]
   742   C3146302:Mutagenesis [Laboratory Procedure]
   742   C3273202:Kit [Manufactured Object]
   708   C0439851:Direct [Qualitative Concept]
   708   C1947931:Direct [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.40: The mutagenic primer pairs were as follows: 5'-TATAATGCAGAAAGCAGAGAAAGGGAG-3' and 3'-ATATTACGTCTTTCGTCTCTTTCCCTC-5' for site T320R; 

Phrase: "The mutagenic primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "5'-TATAATGCAGAAAGCAGAGAAAGGGAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-ATATTACGTCTTTCGTCTCTTTCCCTC-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site T320R"

Phrase: ";"
Processing 00000000.tx.41: 5'-GAAAGGGAGGCACAAGACACTGTTG-3' and 3'-CTTTCCCTCCGTGTTCTGTGACAAC-5' for site S324A; 

Phrase: "5'-GAAAGGGAGGCACAAGACACTGTTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-CTTTCCCTCCGTGTTCTGTGACAAC-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site S324A"

Phrase: ";"
Processing 00000000.tx.42: 5'-TATAATGCAGAAAGCAGAGAAAGGGAGGCACAAGACACTGTTG and 3'-ATATTACGTCTTTCGTCTCTTTCCCTCCGTGTTCTGTGACAAC for both sites T320R,S324A; 

Phrase: "5'-TATAATGCAGAAAGCAGAGAAAGGGAGGCACAAGACACTGTTG"

Phrase: "and"

Phrase: "3'-ATATTACGTCTTTCGTCTCTTTCCCTCCGTGTTCTGTGACAAC for both sites T320R,"

Phrase: "S324A"

Phrase: ";"
Processing 00000000.tx.43: 5'-CTAGGGCCTCATCGCGCTACACCTGAG-3' and 3'-GATCCCGGAGTAGCGCGATGTGGACTC-5' for site S353A; 

Phrase: "5'-CTAGGGCCTCATCGCGCTACACCTGAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-GATCCCGGAGTAGCGCGATGTGGACTC-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site S353A"

Phrase: ";"
Processing 00000000.tx.44: 5'-CTACACCTGAGGCACGAGCTGCTGTCC-3' and 3'-GATGTGGACTCCGTGCTCGACGACAGG-5' for site S357A; 

Phrase: "5'-CTACACCTGAGGCACGAGCTGCTGTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-GATGTGGACTCCGTGCTCGACGACAGG-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site S357A"

Phrase: ";"
Processing 00000000.tx.45: 5'-CTAGGGCCTCATCGCGCTACACCTGAGGCACGAGCTGCTGTCC-3' and 3'-GATCCCGGAGTAGCGCGATGTGGACTCCGTGCTCGACGACAGG-5' for both site S353A,S357A; 

Phrase: "5'-CTAGGGCCTCATCGCGCTACACCTGAGGCACGAGCTGCTGTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-GATCCCGGAGTAGCGCGATGTGGACTCCGTGCTCGACGACAGG-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for both site S353A,"

Phrase: "S357A"

Phrase: ";"
Processing 00000000.tx.46: 5'-GGTTGGTAAAGCCGCAGCAACAGCC-3' and 3'-CCAACCATTTCGGCGTCGTTGTCGG-5' for site S397A; 

Phrase: "5'-GGTTGGTAAAGCCGCAGCAACAGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-CCAACCATTTCGGCGTCGTTGTCGG-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site S397A"

Phrase: ";"
Processing 00000000.tx.47: 5'-GCAACAGCCAGAGGAGACTGGAAC-3' and 3'-CGTTGTCGGTCTCCTCTGACCTTG-5' for site S401R; 

Phrase: "5'-GCAACAGCCAGAGGAGACTGGAAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-CGTTGTCGGTCTCCTCTGACCTTG-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for site S401R"

Phrase: ";"
Processing 00000000.tx.48: 5'-CCAACCATTTCGGCGTCGTTGTCGGTCTCCTCTGACCTTG-3' and 3'-GGTTGGTAAAGCCGCAGCAACAGCCAGAGGAGACTGGAAC-5' for both site S397A,S401R. 

Phrase: "5'-CCAACCATTTCGGCGTCGTTGTCGGTCTCCTCTGACCTTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3'-GGTTGGTAAAGCCGCAGCAACAGCCAGAGGAGACTGGAAC-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442758:3 5 [Quantitative Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "for both site S397A,"

Phrase: "S401R."
Processing 00000000.tx.49: The fidelity of polymerase chain reaction replication and introduction of each corresponding PS1 mutation (underlined) was confirmed by DNA sequence analysis. 

Phrase: "The fidelity of polymerase chain reaction replication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680011:fidelity [Social Behavior]

Phrase: "and"

Phrase: "introduction of each corresponding PS1 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1293116:Introduction [Health Care Activity]
   753   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "(underlined"

Phrase: ")"

Phrase: "was"

Phrase: "confirmed by DNA sequence analysis."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   862   C0162802:Sequence Analysis, DNA [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   806   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   797   C0200898:DNA analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1519249:Sequence [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.50: Luciferase Reporter Assay-- For reporter gene assays, 293HEK cells were transfected with 0.1g of Tcf-luciferase reporter gene plasmid, TOPFLASH, (Upstate Biotechnology, Inc.) and the indicated amount of each expression construct. 

Phrase: "Luciferase Reporter Assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   827   C0243073:assay [Qualitative Concept]
   827   C0335038:Reporter [Professional or Occupational Group]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827   C1705915:Reporter [Conceptual Entity]
   827   C1709908:Reporter [Group]

Phrase: "-"

Phrase: "-"

Phrase: "For reporter gene assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0206414:Reporter Gene [Gene or Genome]

Phrase: "293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 0.1g of Tcf-luciferase reporter gene plasmid,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0206414:Reporter Gene [Gene or Genome]
   757   C1334435:Luciferase Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0335038:Reporter [Professional or Occupational Group]
   739   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   739   C1705915:Reporter [Conceptual Entity]
   739   C1709908:Reporter [Group]

Phrase: "TOPFLASH,"

Phrase: "(Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "and"

Phrase: "the indicated amount of each expression construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.51: The total concentration of transfected DNA was kept constant by supplementation with empty vector. 

Phrase: "The total concentration of transfected DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086045:Concentration [Mental Process]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "constant by supplementation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1547014:*Constant [Quantitative Concept]
   790   C1948059:Constant [Qualitative Concept]

Phrase: "with empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.52: Cells were harvested 24h post-transfection, and the reporter activity was determined with the Luciferase Assay System (Promega). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24h post-transfection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456696:/24h [Temporal Concept]
   827   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "the reporter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined with the Luciferase Assay System"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0449913:System [Functional Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.53: In Vitro and in Vivo Phosphorylation-- Assessment of the PS1 consensus phosphorylation motif was carried out in vitro according to the method described by Dong et al. 

Phrase: "In Vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in Vivo Phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "--"

Phrase: "Assessment of the PS1 consensus phosphorylation motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in vitro according to the method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "described by Dong et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.54: (17) with only minor changes. 

Phrase: "(17"

Phrase: ")"

Phrase: "with only minor changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.55: Briefly, synthetic peptide (30-50 M) containing either the Ser353, Ser357 motif (NH2-GPHRSTPESRAAV-COOH) or an altered motif to substitute the serine residues for alanine (NH2-GPHRATPEARAAV-COOH) (S353A,S357A), was incubated with 5units of kinase, 10M ATP, and 2Ci of [-32P]ATP at 111TBq/mmol (Amersham Pharmacia Biotech) for 60min at 37C. 

Phrase: "Briefly,"

Phrase: "synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "(30-50"

Phrase: "M)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either"

Phrase: "the Ser353,"

Phrase: "Ser357 motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "(NH2-GPHRSTPESRAAV-COOH"

Phrase: ")"

Phrase: "or"

Phrase: "an altered motif to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "substitute"

Phrase: "the serine residues for alanine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(NH2-GPHRATPEARAAV-COOH"

Phrase: ")"

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "incubated with 5units of kinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "10M ATP,"

Phrase: "and"

Phrase: "2Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]ATP at 111TBq/mmol (Amersham Pharmacia Biotech"

Phrase: ")"

Phrase: "for 60min"

Phrase: "at 37C."
Processing 00000000.tx.56: Incorporation of radiolabeled phosphate was determined by adsorption of the peptide to P81 membranes and scintillation counting. 

Phrase: "Incorporation of radiolabeled phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "determined by adsorption of the peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001674:Adsorption [Laboratory Procedure]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "to P81 membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "scintillation counting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036406:Scintillation Counting [Laboratory Procedure]
   827   C0750480:Count [Activity]
   827   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.57: Synthetic PS1 peptides used for in vitro kinase studies were obtained from American Peptide Co. 

Phrase: "Synthetic PS1 peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "used for in vitro kinase studies"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   804   C0681828:in vitro study [Research Activity]
           studies vitro
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   767   C0869040:Use studies [Research Activity]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0947630:studies [Laboratory Procedure]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C1947944:Use [Intellectual Product]
   719 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "obtained from American Peptide Co."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0596070:American [Population Group]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.58: GSK-3 (rabbit), produced by recombinant methods, was purchased from Sigma or New England Biolabs. 

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "produced by recombinant methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C1514798:recombinant [Organism]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "or"

Phrase: "New England Biolabs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]
Processing 00000000.tx.59: Other kinases were acquired as follows: casein kinase II from Sigma, protein kinase C from Promega, p38 from Upstate Biotechnology, and p38 produced at Scios Inc. 

Phrase: "Other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "casein kinase II from Sigma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protein kinase C from Promega,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C1168438:Protein C [Laboratory Procedure]
   797   C1418943:PROTEIN C [Gene or Genome]
   797   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "p38 from Upstate Biotechnology,"

Phrase: "and"

Phrase: "p38"

Phrase: "produced at Scios Inc."
Processing 00000000.tx.60: Control reactions using cognate substrates for each kinase were performed in an identical fashion. 

Phrase: "Control reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cognate substrates for each kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "performed in an identical fashion."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.61: In vivo phosphorylation was carried out using 293HEK cells transiently transfected with wild type or GSK-3 mutant PS1 DNA. 

Phrase: "In vivo phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "293HEK cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "GSK-3 mutant PS1 DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.62: Twenty-seven hours post-transfection, cell monolayers were washed, incubated for 1h in phosphate-free medium supplemented with 10% dialyzed fetal bovine serum, washed, and radiolabeled for 4h with 0.5mCi/ml [32P]orthophosphate (Amersham Pharmacia Biotech). 

Phrase: "Twenty-seven hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "cell monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "in phosphate-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "dialyzed"

Phrase: "fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "radiolabeled for 4h"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1292426:4H [Temporal Concept]
   790   C1527121:Radiolabeled [Qualitative Concept]
   756 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with 0.5mCi/ml [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.63: Cell lysates were prepared in 10mM HEPES, 10mM KCl, 500mM NaCl, 1% Nonidet P-40, 50mM NaF, 0.2mM sodium orthovanadate, 10mM imidazole, and protease inhibitor mixture (Roche Molecular Biochemicals) prepared without EDTA. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "prepared in 10mM HEPES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   737   C1521827:Prepare [Functional Concept]

Phrase: "10mM KCl,"

Phrase: "500mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "50mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "0.2mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029366:Orthovanadate [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "10mM imidazole,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   861   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "prepared without EDTA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   756   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.64: Lysates were incubated overnight at 4C with nickel beads (Qiagen), washed first in complete lysis buffer and then in lysis buffer without 500mM NaCl. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "with nickel beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "first in complete lysis buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "then in lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1883708:Then [Temporal Concept]

Phrase: "without 500mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.65: Protein bound to the beads was eluted with lysis buffer lacking 500mM NaCl and supplemented with 100mM imidazole. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to the beads"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "was"

Phrase: "eluted with lysis buffer lacking 500mM NaCl"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0332268:Lacking [Qualitative Concept]
   748   C1536403:lysis [Cell Function]
   748   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "supplemented with 100mM imidazole."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   770   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.66: The elute was adjusted to 2mM EDTA, and PS1 was immunoprecipitated with a tetra-His monoclonal antibody followed by electrophoresis of the precipitate on a 12% NuPage Tris/glycine gel (Novex) as described below. 

Phrase: "The"

Phrase: "elute"

Phrase: "was"

Phrase: "adjusted to 2mM EDTA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   770   C0456081:Adjusted [Functional Concept]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated with a tetra-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039644:TETRA [Antibiotic,Organic Chemical]
   770   C1010255:tetra [Fish]
   770   C1010292:Tetra [Fish]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "His monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "followed by electrophoresis of the precipitate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C1882443:PRECIPITATE [Phenomenon or Process]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "on a 12% NuPage Tris/glycine gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "(Novex"

Phrase: ")"

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.67: The gel was dried and exposed for 48h using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "exposed for 48h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332157:Exposed [Clinical Attribute]
   790   C1442464:48H [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager"

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.68: Sample dephosphorylation was carried out using calf intestinal alkaline phosphatase (New England Biolabs) by adding 300units of enzyme during the final hour of the immunoprecipitation step. 

Phrase: "Sample dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158884:Dephosphorylation [Molecular Function]
   861   C3160734:Dephosphorylation [Molecular Function]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "calf intestinal alkaline phosphatase"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   923   C0134983:intestinal alkaline phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1412363:ALKALINE PHOSPHATASE, INTESTINAL [Gene or Genome]
   861   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0230445:Calf [Body Location or Region]
   812   C1149880:phosphatase [Molecular Function]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1979842:Alkaline [Qualitative Concept]
   756 E C0626053:sural [Pharmacologic Substance]
   741 E C1708548:INTESTINE [Tissue]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: "by adding 300units"

Phrase: "of enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "during the final hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "of the immunoprecipitation step."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]
Processing 00000000.tx.69: Cell Death Assays-- Human 293HEK cells (3105) were transiently transfected with 0.01mg of a green fluorescent protein reporter plasmid (pGFP) plus the indicated concentration of test plasmid in six-well tissue culture dishes. 

Phrase: "Cell Death Assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0007587:Cell Death [Cell Function]

Phrase: "--"

Phrase: "Human 293HEK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0427861:Human cells [Laboratory or Test Result]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(3105"

Phrase: ")"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with 0.01mg of a green fluorescent protein reporter plasmid"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   775   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   738   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C0332583:Green [Qualitative Concept]
   738   C0335038:Reporter [Professional or Occupational Group]
   738   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   738   C1705915:Reporter [Conceptual Entity]
   738   C1709908:Reporter [Group]

Phrase: "(pGFP"

Phrase: ")"

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "the indicated concentration of test plasmid in six-well tissue culture dishes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.70: Twenty-four hours post-transfection, the cells were induced to undergo apoptosis. 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.71: Cells were then fixed in 3.7% formaldehyde and were visualized by microscopy. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed in 3.7% formaldehyde"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1298529:Formaldehyde 3.7% [Clinical Drug]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "were"

Phrase: "visualized by microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026018:Microscopy [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
   718 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.72: Approximately 300green fluorescent protein-positive cells were assessed from each transfection (n=3) from three randomly selected fields, and the mean of these was used to calculate percentage of apoptosis. 

Phrase: "Approximately 300green fluorescent protein-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0439178:% positive cells [Quantitative Concept]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "assessed from each transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C1516048:Assessed [Activity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "from three randomly selected fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "and"

Phrase: "the mean of these"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "percentage of apoptosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.73: Viable or apoptotic cells were distinguished based on morphological alterations typical of adherent cells undergoing apoptosis including becoming rounded, condensed, membrane-blebbing, and detached from the culture dish. 

Phrase: "Viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "or"

Phrase: "apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "distinguished"

Phrase: "based on morphological alterations"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0543482:morphological [Spatial Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   766   C1260954:Morphologic alteration [Anatomical Abnormality]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1515926:Alteration [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "typical of adherent cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "undergoing"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "becoming"

Phrase: "rounded,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]

Phrase: "condensed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1155631:Condensed [Cell Function]

Phrase: ","

Phrase: "membrane-blebbing,"

Phrase: "and"

Phrase: "detached from the culture dish."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0687118:Detached [Functional Concept]
   760   C1561504:detached [Idea or Concept]
Processing 00000000.tx.74: Coimmunoprecipitation and Western Blot Analysis-- HEK293 cells were transiently transfected with the indicated constructs. 

Phrase: "Coimmunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western Blot Analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C2827421:Construct [Classification]
Processing 00000000.tx.75: Cells were harvested 24-48 h post-transfection. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24-48 h post-transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.76: For coimmunoprecipitation, cells in 100-mm plates were washed twice with ice-cold phosphate-buffered saline and lysed in 1ml of lysis buffer (50mM HEPES, 150mM NaCl, 2mM EDTA, 0.1% Nonidet P-40, and protease inhibitor mixture (CompleteTM, Roche Molecular Biochemicals). 

Phrase: "For coimmunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "cells in 100-mm plates"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C1441340:100 cells [Cell]
   781   C1166718:cells plate [Cell Component]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold phosphate-buffered saline"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "lysed in 1ml of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
           lysed
   753   C1536403:lysis [Cell Function]

Phrase: "(50mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "2mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(CompleteTM,"

Phrase: "Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.77: Cells were lysed on ice for 15min and then spun at 14,000rpm for 20min, and the supernatants were collected. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0024348:lysed [Pathologic Function]

Phrase: "for 15min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "spun at 14,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000rpm for 20min,"

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.78: Lysates were precleared with 50l of protein G-agarose beads (Roche Molecular Biochemicals) and immunoprecipitated with 5g of tetra-His monoclonal antibody (Qiagen). 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "precleared with 50l of protein G-agarose beads"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0060916:protein g [Amino Acid, Peptide, or Protein]
   767 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036681:Agarose [Carbohydrate]
   744   C0439267:g% [Quantitative Concept]
   744   C0991566:Beads [Biomedical or Dental Material]
   711 E C2346972:Bead [Spatial Concept]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "immunoprecipitated with 5g of tetra-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039644:TETRA [Antibiotic,Organic Chemical]
   760   C1010255:tetra [Fish]
   760   C1010292:Tetra [Fish]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "His monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.79: Immunoprecipitates were washed five times in lysis buffer and resolved on either 4-12% or 10% NuPage Bis-Tris gels (Novex). 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times in lysis buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "resolved on either 4-12%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "or"

Phrase: "10% NuPage Bis-Tris gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "(Novex"

Phrase: ")."
Processing 00000000.tx.80: For Western blots, lysates were prepared in an identical manner. 

Phrase: "For Western blots,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared in an identical manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.81: The PS1 monoclonal antibody directed to the C-terminal "loop" domain (3.6.1) was obtained by immunizing mice with a synthetic peptide spanning PS1 residues 309-331. 

Phrase: "The PS1 monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "directed to the C-terminal """
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1707271:C-Terminal [Amino Acid Sequence]
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: """ domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(3.6.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0442759:3 6 [Finding]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "obtained by immunizing mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "with a synthetic peptide spanning PS1 residues 309-331."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   818   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   795   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1418985:PS1 [Gene or Genome]
   795   C1883254:synthetic [Activity]
   795   C2986918:PS1 [Gene or Genome]
   762   C1709915:Residue [Conceptual Entity]
   762   C1711300:Span [Conceptual Entity]
   762   C1882936:RESIDUE [Phenomenon or Process]
   762   C2700613:Span [Quantitative Concept]
   712 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.82: The rat anti-human PS1 N-terminal antibody was purchased from Chemicon. 

Phrase: "The rat anti-human PS1 N-terminal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Chemicon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.83: Comparison of PS1 CTFs from His-tagged and untagged constructs was made by transfecting 293HEK cells with each construct for 24h as described above, after which lysates were analyzed by Western blot using antibodies directed to PS1 NTF or CTF. 

Phrase: "Comparison of PS1 CTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "from His-tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "untagged constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "made by transfecting 293HEK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726   C1881534:Make [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "as described above,"

Phrase: "after"

Phrase: "which lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed to PS1 NTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "CTF."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.84: The same samples were immunoprecipitated with anti-His antibody, and then the precipitates were probed by Western blot with the PS1 C-terminal antibody 3.6.1.

Phrase: "The same samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immunoprecipitated with anti-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "His antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "probed by Western blot"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "with the PS1 C-terminal antibody 3.6.1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C1707271:C-Terminal [Amino Acid Sequence]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0205088:Terminal [Temporal Concept]
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1418985:PS1 [Gene or Genome]
   795   C1705314:Terminal [Manufactured Object]
   795   C1705315:Terminal [Spatial Concept]
   795   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.85: The BCA method (Pierce) was used to normalize each sample such that equivalent amount of protein was applied to the gel. 

Phrase: "The BCA method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "such"

Phrase: "that equivalent amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "applied to the gel."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0185125:Applied [Health Care Activity]
   770   C1382104:Gel [Substance]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.86: After gel separation, proteins were transferred to membranes and blotted with antibody. 

Phrase: "After gel separation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036679:Separation [Pathologic Function]
   861   C0237868:Separation [Social Behavior]
   861   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred to membranes"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0025255:Membranes [Tissue]
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C0596901:Membrane [Cell Component]
   756 E C1705822:Transfer [Activity]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "blotted with antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: -Catenin and GSK-3 monoclonal antibodies were purchased from Transduction Laboratories. 

Phrase: "-Catenin"

Phrase: "and"

Phrase: "GSK-3 monoclonal antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0746619:monoclonal [Finding]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "purchased from Transduction Laboratories."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.88: The monoclonal antibody specific for activated GSK-3 Y279/Y216 was purchased from BIOSOURCE International. 

Phrase: "The monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "specific for activated GSK-3 Y279/Y216"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "purchased from BIOSOURCE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "International."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]
Processing 00000000.tx.89: Cytosolic and Nuclear Fractionation-- HEK293 cell cultures in 100-mm plates were washed twice in ice-cold PBS. 

Phrase: "Cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "Nuclear Fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "HEK293 cell cultures in 100-mm plates"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0007585:Cell Cultures [Laboratory Procedure]
   778   C2936239:HEK293 Cell [Cell]
   757   C0180454:culture plates [Medical Device]
   757   C1166718:cell plate [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0010453:Cultures [Idea or Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in ice-cold PBS."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.90: Cells were washed once with ice-cold hypotonic buffer (10mM Hepes, pH 7.4,10mM KCl, 2mM MgCl), resuspended in 500l of hypotonic buffer supplemented with 1mM dithiothreitol, 5M cytochalasin B, and protease inhibitors (CompleteTM; Roche Molecular Biochemicals), and allowed to swell on ice for 15min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with ice-cold hypotonic buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0234192:Cold [Physiologic Function]
   753   C0241938:Hypotonic [Pathologic Function]
   753   C1720092:Once [Intellectual Product]
   753   C1948045:Once [Temporal Concept]

Phrase: "(10mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10mM KCl,"

Phrase: "2mM MgCl"

Phrase: ")"

Phrase: ","

Phrase: "resuspended in 500l of hypotonic buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0241938:Hypotonic [Pathologic Function]

Phrase: "supplemented with 1mM dithiothreitol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "5M cytochalasin B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   827   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(CompleteTM"

Phrase: "; Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to swell on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013604:swell [Pathologic Function]
   770   C0038999:swell [Finding]

Phrase: "for 15min."
Processing 00000000.tx.91: Cells were Dounce homogenized, and the nuclei (and membranes) were removed by centrifugation at 2,000rpm. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "Dounce"

Phrase: "homogenized"

Phrase: ","

Phrase: "and"

Phrase: "the nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "("

Phrase: "and"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "removed by centrifugation at 2,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0849355:Removed [Qualitative Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "000rpm."
Processing 00000000.tx.92: The supernatant was collected and further spun at 100,000g for 45min to provide the cytosolic fraction. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "spun at 100,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000g for 45min to"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the cytosolic fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.93: The pelleted fraction was washed twice in hypotonic buffer, vortexed, lysed by vigorous vortexing in cell lysis buffer, and spun at 14,000rpm, and the supernatant was collected to provide the nuclear fraction. 

Phrase: "The pelleted fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in hypotonic buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "vortexed,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "lysed by vigorous vortexing in cell lysis buffer,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0007634:Cell [Cell]
   744   C0024348:Lysis [Pathologic Function]
           lysed
   744   C0439648:vortexing [Spatial Concept]
   744   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   744   C1269647:Cell [Cell]
   744   C1536403:lysis [Cell Function]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "spun at 14,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000rpm,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the nuclear fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.94: Protein concentrations in the cytosolic and nuclear fractions were determined using the BCA reaction. 

Phrase: "Protein concentrations in the cytosolic"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "nuclear fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.95: A Measurements-- Cultures of 293HEK cells stably expressing the APP Swedish (APPswe) mutation were transiently transfected with wild type PS1, FAD-PS1, or PS1 site-directed mutants with 2g of DNA per well of a six-well plate. 

Phrase: "A Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "--"

Phrase: "Cultures of 293HEK cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "expressing"

Phrase: "the APP Swedish (APPswe) mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with wild type PS1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "FAD-PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "PS1 site-directed mutants with 2g of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "per well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "of a six-well plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.96: Each cDNA was transfected in triplicate, and after 8h, the medium was replaced by 1ml of DMEM-21 containing 0.5% bovine serum albumin, 1% L-glutamine, and antibiotics (50units/ml penicillin and 50g/ml streptomycin). 

Phrase: "Each cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transfected in triplicate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205174:Triplicate [Quantitative Concept]

Phrase: "and after 8h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292429:8H [Temporal Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced by 1ml of DMEM-21"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1299987:Replaced by [Functional Concept]
           replaced
   753   C0559956:Replaced [Functional Concept]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "1% L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "(50units/ml penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "50g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: ")."
Processing 00000000.tx.97: Supernatants were collected 24h post-transfection. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "24h post-transfection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456696:/24h [Temporal Concept]
   827   C1442770:24H [Temporal Concept]
Processing 00000000.tx.98: The supernatants were clarified of cell debris and assayed for A1-40 and A1-42 by sandwich ELISA. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "clarified of cell debris"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0440266:Debris [Substance]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2986669:Clarified [Activity]

Phrase: "and"

Phrase: "assayed for A1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439509:/40 [Temporal Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "A1-42 by sandwich ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.99: Monoclonal antibodies developed by Scios used in the ELISA assays included: 1101.1,raised to residues 12-22 of the A sequence; 

Phrase: "Monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "developed by Scios"

Phrase: "used in the ELISA assays"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   760   C1273517:used [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ":"

Phrase: "1101.1,"

Phrase: "raised to residues 12-22 of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0442818:Raised [Quantitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "A sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.100: a C-terminal A40-specific antibody, 1702.1; 

Phrase: "a C-terminal A40-specific antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "1702.1"

Phrase: ";"
Processing 00000000.tx.101: and a C-terminal A42-specific antibody. 

Phrase: "and"

Phrase: "a C-terminal A42-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.102: Pulse-Chase Analysis-- HEK293 cells were transiently transfected with either mock cDNA, wild type PS1, FAD-PS1, or PS1 site-directed mutants with 2g of DNA per well of a six-well plate as previously described. 

Phrase: "Pulse-Chase Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with either mock cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0562577:mock [Finding]

Phrase: "wild type PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "FAD-PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "PS1 site-directed mutants with 2g of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "per well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "of a six-well plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: "as"

Phrase: "previously"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.103: Twenty-four-hour post-transfection cells were washed twice with ice-cold PBS, and growth medium was replaced with methionine- and cysteine-free medium supplemented with 0.5% bovine serum albumin, 1% L-glutamine, and antibiotics (50units/ml penicillin and 50g/ml streptomycin) and incubated at 37C for 60min. 

Phrase: "Twenty-four-hour post-transfection cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold PBS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with methionine-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0559956:Replaced [Functional Concept]
   790   C1299987:replaced [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "cysteine-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 0.5% bovine serum albumin,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   778   C0444499:0/5 [Quantitative Concept]
   778   C0728877:serum albumin [Laboratory or Test Result]
   774 E C0523465:Albumin - serum [Laboratory Procedure]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007452:Bovine [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "1% L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "(50units/ml penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "50g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: ")"

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 60min."
Processing 00000000.tx.104: At this time, 100mCi/ml [35S]methionine/cysteine was added and incubated for a further 20min. 

Phrase: "At this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "100mCi/ml [35S"

Phrase: "]methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for a further 20min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
Processing 00000000.tx.105: Medium was then removed, and cells were washed and replaced with complete growth medium and chased for 0,1.5,and 3h. 

Phrase: "Medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "replaced with complete growth medium"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0205197:Complete [Qualitative Concept]
   760   C0220844:growth [Physiologic Function]
   760   C0439536:Medium [Quantitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C0725685:COMPLEAT [Food]
   760   C1299987:replaced [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1705217:Medium [Substance]
   760   C2911660:Growth [Activity]
   760   C3244283:medium [Intellectual Product]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "chased for 0,"

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]
Processing 00000000.tx.106: Cells were rinsed two times with ice cold phosphate-buffered saline and lysed in radioimmune precipitation buffer (50mM Tris-HCl, pH 7.4,150mM NaCl, 10mM EDTA, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS) supplemented with protease inhibitors on ice for 15min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "two times with ice cold phosphate-buffered saline"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   770   C0456963:Ice cold [Qualitative Concept]
   770   C1948050:Two Times [Quantitative Concept]
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0040223:times [Temporal Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0234192:Cold [Physiologic Function]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "lysed in radioimmune precipitation buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "(50mM Tris-HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "0.1% SDS)"

Phrase: "supplemented with protease inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1947941:Protease [Enzyme]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737 E C1999216:Inhibitor [Qualitative Concept]
   737   C2348609:Supplement [Functional Concept]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 15min."
Processing 00000000.tx.107: The cell lysates were spun at 14,000rpm and immunoprecipitated with anti--catenin monoclonal antibody, as described above. 

Phrase: "The cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "spun at 14,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000rpm"

Phrase: "and"

Phrase: "immunoprecipitated with anti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "--"

Phrase: "catenin monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.108: Immunoprecipitates were resolved on a 4-12% NuPage Bis-Tris gel (Novex) and analyzed by a PhosphorImager.  

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "resolved on a 4-12% NuPage Bis-Tris gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0053809:Bis-Tris [Organic Chemical]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0556985:BIS [Temporal Concept]
   742   C0814229:TRI [Intellectual Product]
   742   C1382104:Gel [Substance]
   742   C1514893:Resolved [Idea or Concept]
   742   C2247301:BIS [Molecular Function]
   742   C2699488:Resolved [Conceptual Entity]
   742   C3540495:BIS [Intellectual Product]

Phrase: "(Novex"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by a PhosphorImager."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.109: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES PS1 Hydrophilic Loop Domain Contains GSK-3 Consensus Phosphorylation Sites-- PS1 and PS2 encode structurally similar proteins that share a high degree of homology. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PS1 Hydrophilic Loop Domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "Contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "GSK-3 Consensus Phosphorylation Sites"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C0205145:Sites [Spatial Concept]
   795   C1158886:Phosphorylation [Molecular Function]
   785   C1519063:Phosphorylation Site [Amino Acid Sequence]
   762 E C1515974:Site [Body Location or Region]
   762 E C2825164:Site [Spatial Concept]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "structurally similar proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a high degree of homology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.110: Each contain six or eight transmembrane domains with both N- and C-terminal hydrophilic regions and a large hydrophilic loop domain. 

Phrase: "Each"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "or"

Phrase: "eight transmembrane domains with both N-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1519623:Transmembrane Domain [Amino Acid Sequence]
   753   C1167322:transmembrane [Cell Component]
   753   C2752508:transmembrane [Cell Component]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "C-terminal hydrophilic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "a large hydrophilic loop domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.111: From sequence alignment studies, it has been previously shown that the hydrophilic loop domain has the greatest sequence divergence, suggesting that the loop domain may mediate PS1 and PS2 functional differences. 

Phrase: "From sequence alignment studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0080143:Sequence Alignment [Molecular Biology Research Technique]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "the greatest sequence divergence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443204:Divergence [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 functional differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.112: Alignment of the hydrophilic loop domain of PS1 from several species revealed that the loop domain contained a highly conserved sequence containing three potential GSK-3 consensus phosphorylation sites, two of which are conserved in all examined species (Fig. 1A). 

Phrase: "Alignment of the hydrophilic loop domain of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1706765:Alignment [Quantitative Concept]

Phrase: "from several species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a highly conserved sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0009802:Conserved Sequence [Nucleotide Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "three potential GSK-3 consensus phosphorylation sites,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   791   C0031715:Phosphorylation [Molecular Function]
   791   C0205145:Sites [Spatial Concept]
   791   C1158886:Phosphorylation [Molecular Function]
   774   C1519063:Phosphorylation Site [Amino Acid Sequence]
   758 E C1515974:Site [Body Location or Region]
   758 E C2825164:Site [Spatial Concept]

Phrase: "two of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "conserved in all examined species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332128:Examined [Finding]
   760   C1705920:Species [Conceptual Entity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.113: The sequence (S/T)XXXS is known to be a consensus sequence for a GSK-3 phosphorylation site. 

Phrase: "The sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "S/"

Phrase: "T)XXXS"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a consensus sequence for a GSK-3 phosphorylation site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0079160:Consensus Sequence [Nucleotide Sequence]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0376298:Consensus [Social Behavior]
   738   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.114: In the hydrophilic loop region of PS1, residues 263-407, there are three possible phosphorylation sites: TERES324, STPES357 and SATAS401. 

Phrase: "In the hydrophilic loop region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "residues 263-407,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "there"

Phrase: "are"

Phrase: "three possible phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Sites [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "TERES324,"

Phrase: "STPES357"

Phrase: "and"

Phrase: "SATAS401."
Processing 00000000.tx.115: Of the three sites, only STPES357 and SATAS401 are conserved across all examined species. 

Phrase: "Of the three sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "only STPES357"

Phrase: "and"

Phrase: "SATAS401"

Phrase: "are"

Phrase: "conserved across all examined species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332128:Examined [Finding]
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.116: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 1B shows an alignment of PS1 and PS2 hydrophilic loop domains and demonstrates that neither of the GSK-3 consensus phosphorylation sites are present in PS2. 

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an alignment of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "PS2 hydrophilic loop domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "neither of the GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   741   C2945843:Site of [Qualitative Concept]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205145:Sites [Spatial Concept]
   739   C0376298:Consensus [Social Behavior]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C3274651:Neither [Qualitative Concept]
   726   C1519063:Phosphorylation Site [Amino Acid Sequence]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "present in PS2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
Processing 00000000.tx.118: View larger version (57K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.120: Sequence analysis of PS1 hydrophilic loop domain. 

Phrase: "Sequence analysis of PS1 hydrophilic loop domain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0936012:Analysis [Research Activity]
   748   C1519249:Sequence [Functional Concept]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.121: A, the hydrophilic loop domain of PS1 and its amino acid sequence homology across species. 

Phrase: "A,"

Phrase: "the hydrophilic loop domain of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "its amino acid sequence homology across species."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   853   C0162777:Sequence Homology, Amino Acid [Quantitative Concept]
   803 E C0162776:Homologs, Amino Acid Sequence [Amino Acid Sequence]
   778   C0162775:Sequence Homology [Quantitative Concept]
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]
   728 E C0162774:Sequence Homolog [Molecular Sequence]
Processing 00000000.tx.122: Alignments were done with Megalign (DNASTAR) software. 

Phrase: "Alignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706765:Alignment [Quantitative Concept]

Phrase: "were"

Phrase: "done with Megalign"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "(DNASTAR"

Phrase: ")"

Phrase: "software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.123: Residues that fit the consensus sequence for GSK-3 phosphorylation are indicated in boldface type and are boxed. 

Phrase: "Residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "the consensus sequence for GSK-3 phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0079160:Consensus Sequence [Nucleotide Sequence]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0376298:Consensus [Social Behavior]
   742   C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "indicated in boldface type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "boxed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]
Processing 00000000.tx.124: B, alignment of PS1 and PS2 hydrophilic loop domains. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "alignment of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "PS2 hydrophilic loop domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.125: The residues that fit the consensus sequence for GSK-3 phosphorylation, present in PS1 but absent from PS2, are indicated in boldface type and are boxed. 

Phrase: "The residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "the consensus sequence for GSK-3 phosphorylation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0079160:Consensus Sequence [Nucleotide Sequence]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0376298:Consensus [Social Behavior]
   742   C1519249:Sequence [Functional Concept]

Phrase: "present in PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "absent from PS2,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: "are"

Phrase: "indicated in boldface type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "boxed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]
Processing 00000000.tx.126: C, alignment of amino acid sequences recognized as GSK-3 phosphorylation consensus motifs. 

Phrase: "C,"

Phrase: "alignment of amino acid sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   760   C1706765:Alignment [Quantitative Concept]

Phrase: "recognized as GSK-3 phosphorylation consensus motifs."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0376298:Consensus [Social Behavior]
   742   C1158886:Phosphorylation [Molecular Function]
   708   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.127: Shading indicates amino acids that are identical in all substrates. 

Phrase: "Shading"

Phrase: "indicates"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "identical in all substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.128: D, schematic representation of full-length PS1. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "schematic representation of full-length PS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514861:Representation [Conceptual Entity]
   753   C1882932:Representation [Activity]
Processing 00000000.tx.129: The arrows indicate the location of GSK-3 consensus phosphorylation residues that were mutated. 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the location of GSK-3 consensus phosphorylation residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0450429:Location [Spatial Concept]
   739   C1515974:Location [Body Location or Region]

Phrase: "that"

Phrase: "were"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.130: In addition to -catenin, both APC and Axin are also GSK-3 substrates, and their ability to bind -catenin in vitro is enhanced by phosphorylation. 

Phrase: "In addition to -catenin,"

Phrase: "both APC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
           Adenomatous polyposis
           Polyposis Coli
   861   C0162832:adenomatous polyposis coli [Gene or Genome]
   799   C0238767:Both [Spatial Concept]
   799   C0334108:Polyposis [Neoplastic Process]
   799   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "Axin"

Phrase: "are"

Phrase: "also GSK-3 substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1710236:Substrate [Manufactured Object]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "catenin"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "is"

Phrase: "enhanced by phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]
   790   C2349975:Enhanced [Activity]
Processing 00000000.tx.131: The sites necessary for GSK-3 phosphorylation have been identified, and mutating these sites leads to a disruption in the association between -catenin and APC or Axin. 

Phrase: "The sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "necessary for GSK-3 phosphorylation"

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "leads to a disruption"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0332453:Disruption [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "between -catenin"

Phrase: "and"

Phrase: "APC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "or"

Phrase: "Axin."
Processing 00000000.tx.132: Alignment of the amino acid sequence of Axin, APC, -catenin, and PS1 reveals a conserved consensus motif (Fig. 1C). 

Phrase: "Alignment of the amino acid sequence of Axin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   744   C1706765:Alignment [Quantitative Concept]

Phrase: "APC, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "catenin,"

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a conserved consensus motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.133: Since this motif is conserved in PS1 and not PS2, it seems likely that these identified GSK-3 consensus phosphorylation sites mediate a specific PS1 function(s). 

Phrase: "Since"

Phrase: "this motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "conserved in PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "not PS2,"

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "these identified GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   793   C0031715:Phosphorylation [Molecular Function]
   793   C0205145:Sites [Spatial Concept]
   793   C1158886:Phosphorylation [Molecular Function]
   779   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760 E C1515974:Site [Body Location or Region]
   760 E C2825164:Site [Spatial Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "a specific PS1 function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.134: Specifically, we sought to address whether the GSK-3 motifs present on PS1 are used to mediate PS1 binding to -catenin. 

Phrase: "Specifically,"

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "the GSK-3 motifs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1514562:Motif [Amino Acid Sequence]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "present on PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150312:Present [Quantitative Concept]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0449450:Present [Idea or Concept]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "PS1 binding to -catenin."
Processing 00000000.tx.135: The general location of each GSK-3 consensus phosphorylation motif on the PS1 hydrophilic loop domain is schematically shown in Fig. 

Phrase: "The general location of each GSK-3 consensus phosphorylation motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0450429:Location [Spatial Concept]
   736   C1515974:Location [Body Location or Region]

Phrase: "on the PS1 hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "schematically"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: 1D. 

Phrase: "1D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]
Processing 00000000.tx.137: Characterization of PS1 Mutants-- Each of the three consensus GSK-3 phosphorylation motifs present on PS1 was mutated. 

Phrase: "Characterization of PS1 Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "-"

Phrase: "-"

Phrase: "Each of the three consensus GSK-3 phosphorylation motifs"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205449:Three [Quantitative Concept]
   738   C0376298:Consensus [Social Behavior]
   738   C1158886:Phosphorylation [Molecular Function]
   738   C1457900:Each [Quantitative Concept]
   704   C1514562:Motif [Amino Acid Sequence]

Phrase: "present on PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150312:Present [Quantitative Concept]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0449450:Present [Idea or Concept]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.138: Within each GSK-3 motif, the critical serine and threonine codons of all three (S/T)XXXS consensus sites were either individually or both mutated. 

Phrase: "Within each GSK-3 motif,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514562:Motif [Amino Acid Sequence]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the critical serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "threonine codons of all three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009221:Codon [Nucleotide Sequence]
   760   C1095825:Codon [Plant]

Phrase: "("

Phrase: "S/"

Phrase: "T)XXXS consensus sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "either individually"

Phrase: "or"

Phrase: "both"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.139: Table I summarizes the 14different PS1 mutants we generated, the specific residues mutated, and the nomenclature used to reference each mutant. 

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "summarizes"

Phrase: "the 14different PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "the specific residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "and"

Phrase: "the nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600281:Nomenclature [Intellectual Product]
  1000   C1524067:Nomenclature [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "each mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.140: Prior to analyzing the effect of mutating the PS1 GSK-3 motifs relative to -catenin binding and function, we first assessed their influence on two other PS1 functions: endoproteolysis and A production.  

Phrase: "Prior to analyzing"

Phrase: "the effect of mutating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the PS1 GSK-3 motifs relative to -catenin binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   880   C3270761:glycogen binding [Molecular Function]
   857   C1149289:kinase binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "their influence on two"

Phrase: "other PS1 functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "endoproteolysis"

Phrase: "and"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.141: View this table: [in this window] [in a new window]  Table I Summary of GSK-3 phosphorylation site-specific mutant constructs PS1 is synthesized as a 46-kDa polypeptide that undergoes endoproteolytic processing to generate an ~26-kDa N-terminal fragment and ~20-kDa C-terminal fragment (CTF), which are the predominant in vivo detected PS1 species (18-20). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Summary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552616:summary [Intellectual Product]
   827   C1706244:Summary [Intellectual Product]

Phrase: "of GSK-3 phosphorylation site-specific mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "synthesized as a 46-kDa polypeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   753   C1532717:kDa [Quantitative Concept]
   753   C1883254:Synthesized [Activity]

Phrase: "that"

Phrase: "undergoes"

Phrase: "endoproteolytic processing to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709694:Processing [Activity]

Phrase: "generate"

Phrase: "an ~26-kDa N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragment [Functional Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "and ~"

Phrase: "20-kDa C-terminal fragment (CTF),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragment [Functional Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "the predominant in vivo detected PS1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1705920:Species [Conceptual Entity]

Phrase: "(18-20"

Phrase: ")."
Processing 00000000.tx.142: Epitope mapping and radiosequence analysis have shown that PS1 endoproteolysis occurs within the hydrophilic loop domain (21). 

Phrase: "Epitope mapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242831:Epitope Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1283195:Mapping [Activity]

Phrase: "and"

Phrase: "radiosequence analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS1 endoproteolysis"

Phrase: "occurs within the hydrophilic loop domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C0475370:Hydrophilic [Qualitative Concept]
   753   C1709305:Occur [Activity]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.143: Therefore, we determined whether the consensus site mutations altered PS1 endoproteolysis, reflecting a requirement for GSK-3 phosphorylation. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "the consensus site mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "PS1 endoproteolysis,"

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "a requirement for GSK-3 phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.144: To confirm expression and to evaluate effects on the endoproteolytic processing of PS1, subconfluent 293HEK cell cultures were transiently transfected with wild type or mutant PS1, each tagged with a His epitope to distinguish exogenous from endogenous PS1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "effects on the endoproteolytic processing of PS1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "subconfluent 293HEK cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0010453:Cultures [Idea or Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "each"

Phrase: "tagged with a"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   790   C1708632:Tagged [Qualitative Concept]
   756 E C0037293:Tag [Neoplastic Process]
   756 E C0181496:Tag [Manufactured Object]
   756 E C1710492:TAG [Gene or Genome]

Phrase: "His epitope to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "distinguish"

Phrase: "exogenous from endogenous PS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205101:Exogenous [Spatial Concept]
   770   C0205228:Exogenous [Functional Concept]
Processing 00000000.tx.145: Western blot analysis of cell lysates with anti-His monoclonal antibody demonstrated the presence of PS1 holoprotein migrating at ~46 kDa, as well as increased amounts of the ~20-kDa CTF, compared with mock transfected cell lysates (Fig. 2A, upper panel). 

Phrase: "Western blot analysis of cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "with anti-"

Phrase: "His monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "demonstrated"

Phrase: "the presence of PS1 holoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "at ~46 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "as well as"

Phrase: "increased amounts of the ~20-kDa CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:amounts [Quantitative Concept]

Phrase: "compared with mock transfected cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate
   753   C0007634:Cell [Cell]
   753   C0562577:mock [Finding]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1707455:Compared [Activity]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2A,"

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.146: These results demonstrate that the mutation of any or all of the GSK-3 phosphorylation consensus sites on the PS1 loop domain does not affect the regulated endoproteolytic processing of PS1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the mutation of any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "all of the GSK-3 phosphorylation consensus sites"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1510853:All Sites [Spatial Concept]
   741   C1519063:Phosphorylation Site [Amino Acid Sequence]
   741   C2945843:Site of [Qualitative Concept]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205145:Sites [Spatial Concept]
   739   C0376298:Consensus [Social Behavior]
   739   C0444868:All [Quantitative Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C3539085:All [Idea or Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "on the PS1 loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the regulated endoproteolytic processing of PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]
Processing 00000000.tx.147: Western blot analysis of 293HEK cells transiently expressing tagged or untagged PS1 using PS1 N- and C-terminal specific antibodies and immunoprecipitation with an anti-His-antibody followed by Western blot with PS1 C-terminal specific antibody documented the authenticity of the tagged PS1-CTF (Fig. 2A), reflecting endoproteolysis and replacement of endogenous PS1-CTF, although endoproteolysis was somewhat inefficient compared with untagged exogenous PS1 (Fig. 2A, lower panels). 

Phrase: "Western blot analysis of 293HEK cells transiently"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "expressing"

Phrase: "tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "untagged PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoprecipitation with an anti-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "His-antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by Western blot"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with PS1 C-terminal specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "the authenticity of the tagged PS1-CTF"

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "endoproteolysis"

Phrase: "and"

Phrase: "replacement of endogenous PS1-CTF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035139:Replacement [Therapeutic or Preventive Procedure]
   748   C0559956:Replacement [Functional Concept]
   748   C1555302:Replacement [Idea or Concept]

Phrase: "although"

Phrase: "endoproteolysis"

Phrase: "was"

Phrase: "somewhat inefficient"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231185:Inefficient [Functional Concept]
   789 E C0231184:Inefficiency [Finding]

Phrase: "compared with untagged exogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1707455:Compared [Activity]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "(Fig. 2A,"

Phrase: "lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.148: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.149: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.150: Endoproteolysis and A generation by PS1 GSK-3 phosphorylation motif mutants. 

Phrase: "Endoproteolysis"

Phrase: "and"

Phrase: "A generation by PS1 GSK-3 phosphorylation motif mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079411:Generation [Temporal Concept]
   738   C3146294:Generation [Activity]
Processing 00000000.tx.151: A, effects of GSK-3 mutations on PS1 endoproteolysis. 

Phrase: "A,"

Phrase: "effects of GSK-3 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on PS1 endoproteolysis."
Processing 00000000.tx.152: Subconfluent cultures of 293HEK cells were transiently transfected with wild type or the indicated mutant PS1 cDNAs. 

Phrase: "Subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "the indicated mutant PS1 cDNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.153: Twenty-four hours post-transfection, cell extracts were prepared, and expression and endoproteolysis were assessed by protein immunoblot analysis with anti-His monoclonal antibody (upper panel). 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "endoproteolysis"

Phrase: "were"

Phrase: "assessed by protein immunoblot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with anti-"

Phrase: "His monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.154: FL, full-length PS1; 

Phrase: "FL,"

Phrase: "full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.155: NTF and CTF, PS1 N- and C-terminal fragments, respectively. 

Phrase: "NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal fragments,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.156: The asterisk denotes an irreproducible band recognized variably by anti-His antibody (refer also to Fig. 2A, lower right panel, and Fig. 4D). 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "denotes"

Phrase: "an irreproducible band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "recognized"

Phrase: "variably by anti-"

Phrase: "His antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "refer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205543:refer [Functional Concept]

Phrase: "also to Fig. 2A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.157: Lysates from transiently expressed wild type PS1 constructs, tagged and lacking the His tag, were compared by Western blot using PS1 N- and C-terminal specific antibodies (lower left and center panels) and by immunoprecipitation with an anti-His antibody followed by Western blot with the PS1 C-terminal antibody (lower right panel). 

Phrase: "Lysates from transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881488:Lysate [Physical Object]

Phrase: "expressed"

Phrase: "wild type PS1 constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the His tag,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037293:Tag [Neoplastic Process]
  1000   C0181496:Tag [Manufactured Object]
  1000   C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "compared by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   770   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "and"

Phrase: "center panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and by immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "with an anti-"

Phrase: "His antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by Western blot"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with the PS1 C-terminal antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.158: B, quantification of PS1 mutant effects on A generation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of PS1 mutant effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "on A generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.159: Subconfluent cultures of 293HEK cells stably expressing APPswe were transiently transfected with the indicated presenilin wild type, FAD, or mutant cDNAs. 

Phrase: "Subconfluent cultures of 293HEK cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   783   C0007585:cells cultures [Laboratory Procedure]
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "expressing"

Phrase: "APPswe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710263:Swedish [Population Group]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated presenilin wild type, FAD,"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   767   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   766   C3463805:Type of Form [Intellectual Product]
           form type
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C1832428:Familial form [Finding]
   753   C1883559:Wild Type [Organism Attribute]
   751   C0277558:Familial disease [Disease or Syndrome]
   751   C0457464:disease type [Intellectual Product]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:familial [Family Group]
   736   C0241888:Familial [Functional Concept]
   736   C0332307:Type [Qualitative Concept]
   736   C0348078:Form [Qualitative Concept]
   736   C0376315:Form [Manufactured Object]
   736   C0445392:Wild [Intellectual Product]
   736   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   736   C1444656:Indicated [Finding]
   736   C1522492:Form [Functional Concept]
   736   C1547052:*Type [Quantitative Concept]
   715 E C0344339:disease family [Finding]

Phrase: "or"

Phrase: "mutant cDNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.160: Twenty-four hours post-transfection, the conditioned medium was collected, and quantitative analysis of secreted A1-40 and A1-42 was performed using two-site ELISAs. 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "the conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "quantitative analysis of secreted A1-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "A1-42"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two-site ELISAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.161: Results are the meanS.D. of a representative experiment performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of a representative experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.162: We next determined whether the GSK-3 phosphorylation sites on PS1 altered the production of A. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "whether"

Phrase: "the GSK-3 phosphorylation sites on PS1"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205145:Sites [Spatial Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   731   C1519063:Phosphorylation Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the production of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.163: PS1 has been shown to influence -secretase function. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence -"

Phrase: "secretase function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.164: This has been best demonstrated in cells harboring PS1 targeted gene disruption where the levels of A are greatly reduced (22). 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "demonstrated in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "gene disruption where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332453:Disruption [Functional Concept]

Phrase: "the levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "greatly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.165: Furthermore, mutations in PS1 associated with FAD have been shown to elevate A42 levels and many have been mapped to the loop domain (1). 

Phrase: "Furthermore,"

Phrase: "mutations in PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with FAD"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   804   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1832428:Familial form [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
   738 E C0344339:disease family [Finding]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "many"

Phrase: "have"

Phrase: "been"

Phrase: "mapped to the loop domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.166: Thus, we were curious if the mutations introduced in PS1 at the GSK-3 motifs would also result in increased levels of A42. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "were"

Phrase: "curious"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0010472:Curiosities [Individual Behavior]

Phrase: "if"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "introduced in PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]
   756   C1292748:introduce [Functional Concept]

Phrase: "at the GSK-3 motifs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1514562:Motif [Amino Acid Sequence]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "would"

Phrase: "also"

Phrase: "result in increased levels of A42."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0205217:Increased [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.167: To measure A production, 293HEK cell cultures stably expressing APP carrying the Swedish mutation (APPswe) were transiently transfected with wild type, FAD PS1 (E280G), or "GSK-3 "mutant PS1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "293HEK cell cultures stably"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0010453:Cultures [Idea or Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "expressing"

Phrase: "APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Swedish mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(APPswe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710263:Swedish [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with wild type, FAD PS1"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   777   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   775   C3463805:Type of Form [Intellectual Product]
           form type
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C1832428:Familial form [Finding]
   760   C1883559:Wild Type [Organism Attribute]
   757   C0277558:Familial disease [Disease or Syndrome]
   757   C0457464:disease type [Intellectual Product]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:familial [Family Group]
   739   C0241888:Familial [Functional Concept]
   739   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332307:Type [Qualitative Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C0445392:Wild [Intellectual Product]
   739   C1418985:PS1 [Gene or Genome]
   739   C1522492:Form [Functional Concept]
   739   C1547052:*Type [Quantitative Concept]
   739   C2986918:PS1 [Gene or Genome]
   722 E C0344339:disease family [Finding]

Phrase: "(E280G"

Phrase: ")"

Phrase: ","

Phrase: "or ""GSK-3 ""mutant PS1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1418985:PS1 [Gene or Genome]
   795   C2986918:PS1 [Gene or Genome]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.168: Twenty-four hours post-transfection, ELISA quantification revealed an increase in A42 in conditioned medium collected from cells expressing PS1-FAD E280G mutant (Fig. 2B). 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "ELISA quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantification [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an increase in A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "collected from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS1-FAD E280G mutant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1832428:Familial form [Finding]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.169: In contrast, A42 production was not significantly changed in cells transfected with either wild type or with PS1 mutated at the conserved GSK-3 motifs (Fig. 2B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "changed in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1705241:Change [Quantitative Concept]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with either wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "mutated at the conserved GSK-3 motifs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   708 E C1513776:Mutate [Genetic Function]
   708   C1514562:Motif [Amino Acid Sequence]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.170: This suggests that mutation of the GSK-3 consensus phosphorylation sites does not influence the production of A42. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mutation of the GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0026882:Mutation [Genetic Function]
   738   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the production of A42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.171: Interaction of PS1 with -Catenin Requires Ser353 or Ser357-- It has previously been shown that the association between -catenin and APC or Axin can be disrupted by mutating their GSK-3 consensus phosphorylation sites (12, 23, 24). 

Phrase: "Interaction of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with -Catenin"

Phrase: "Requires"

Phrase: "Ser353"

Phrase: "or"

Phrase: "Ser357"

Phrase: "-"

Phrase: "-"

Phrase: "It"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the association between -catenin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "APC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "or"

Phrase: "Axin"

Phrase: "can"

Phrase: "be"

Phrase: "disrupted by mutating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332454:Disrupted [Qualitative Concept]
   756   C1513776:Mutate [Genetic Function]

Phrase: "their GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C0205145:Sites [Spatial Concept]
   795   C1158886:Phosphorylation [Molecular Function]
   785   C1519063:Phosphorylation Site [Amino Acid Sequence]
   762 E C1515974:Site [Body Location or Region]
   762 E C2825164:Site [Spatial Concept]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(12,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.172: Since PS1 has been shown to interact with -catenin (5-7) and we have identified GSK-3 phosphorylation sites on PS1, we examined whether mutating these sites to nonfunctional sequences for kinase recognition would affect the association between PS1 and -catenin. 

Phrase: "Since"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with -catenin"

Phrase: "(5-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "identified GSK-3 phosphorylation sites on PS1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205145:Sites [Spatial Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   731   C1519063:Phosphorylation Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "these sites to nonfunctional sequences"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "for kinase recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "would"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin."
Processing 00000000.tx.173: Subconfluent 293HEK cell cultures were transfected with expression constructs that directed the synthesis of His epitope-tagged wild type or PS1 GSK-3 mutant. 

Phrase: "Subconfluent 293HEK cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0010453:Cultures [Idea or Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transfected with expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "that"

Phrase: "directed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439851:Direct [Qualitative Concept]
   966   C1947931:Direct [Qualitative Concept]

Phrase: "the synthesis of His epitope-tagged wild type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]

Phrase: "or"

Phrase: "PS1 GSK-3 mutant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.174: Consistent with previous reports (6-7), immunoprecipitation of wild type PS1 quantitatively coprecipitated endogenous -catenin (Fig. 3A). 

Phrase: "Consistent with previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(6-7"

Phrase: ")"

Phrase: ","

Phrase: "immunoprecipitation of wild type PS1 quantitatively coprecipitated endogenous -catenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.175: Likewise, PS1 mutant constructs bearing the mutations at residues T320R, S324A, S397A, or S401A also efficiently coimmunoprecipitated endogenous -catenin. 

Phrase: "Likewise,"

Phrase: "PS1 mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the mutations at residues T320R,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "S324A,"

Phrase: "S397A,"

Phrase: "or"

Phrase: "S401A also efficiently coimmunoprecipitated endogenous -catenin."
Processing 00000000.tx.176: However, coimmunoprecipitation of endogenous -catenin was dramatically reduced following expression of PS1 mutants bearing substitutions at residues Ser353 and Ser357 (Fig. 3A). 

Phrase: "However,"

Phrase: "coimmunoprecipitation of endogenous -catenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "dramatically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "expression of PS1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "substitutions at residues Ser353"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1555721:Substitution [Idea or Concept]
   737   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "Ser357"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.177: All of the constructs showed similar levels of PS1 expression (Fig. 3A, lower panel), as well as equal amounts of total and active GSK-3 (data not shown). 

Phrase: "All of the constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C2827421:Construct [Classification]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar levels of PS1 expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C3244092:expression level [Idea or Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "equal amounts of total"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "active GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: Both Ser353 and Ser357 comprise a single GSK-3 phosphorylation motif. 

Phrase: "Both Ser353"

Phrase: "and"

Phrase: "Ser357"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a single GSK-3 phosphorylation motif."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1514562:Motif [Amino Acid Sequence]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.179: To determine whether the association could be attributed to a single residue, we tested two additional constructs, PS1-S353A and PS1-S357A, each bearing a single point mutation at the serine residues within this motif. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "could"

Phrase: "be"

Phrase: "attributed to a single residue,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "two additional constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "PS1-S353A"

Phrase: "and"

Phrase: "PS1-S357A,"

Phrase: "each"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a single point mutation at the serine residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   767   C2924612:A point [Body Location or Region]
   744   C0026882:Mutation [Genetic Function]
   744   C1552961:Point [Quantitative Concept]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C2347617:point [Quantitative Concept]

Phrase: "within this motif."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.180: Coimmunoprecipitation analysis after transient expression of each mutant demonstrated that the ability of PS1 to associate with -catenin was virtually abolished when either Ser353 or Ser357 were mutated (Fig. 3B). 

Phrase: "Coimmunoprecipitation analysis after transient expression of each mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the ability of PS1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "associate with -catenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "virtually"

Phrase: "abolished"

Phrase: "when"

Phrase: "either Ser353"

Phrase: "or"

Phrase: "Ser357"

Phrase: "were"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.181: Together, these results clearly demonstrate that the highly conserved consensus sequence STPES357, containing Ser353 and Ser357, is sufficient and necessary for the association between PS1 and -catenin. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the highly conserved consensus sequence STPES357,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "Ser353"

Phrase: "and"

Phrase: "Ser357,"

Phrase: "is"

Phrase: "sufficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205410:Sufficient [Qualitative Concept]

Phrase: "and"

Phrase: "necessary for the association"

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin."
Processing 00000000.tx.182: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.184: GSK-3 consensus phosphorylation sites on PS1 and interaction with -catenin. 

Phrase: "GSK-3 consensus phosphorylation sites on PS1"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205145:Sites [Spatial Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   731   C1519063:Phosphorylation Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "interaction with -catenin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.185: Subconfluent cultures of 293HEK cells were transiently transfected with the indicated His epitope-tagged wild type or mutant PS1 expression vectors. 

Phrase: "Subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]

Phrase: "His epitope-tagged wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant PS1 expression vectors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.186: Following 24-36 h, extracts were prepared and normalized to ensure equal protein levels in all samples; 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "24-36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "equal protein levels in all samples"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.187: the lysates were immunoprecipitated (IP) with a control monoclonal antibody (C) or an anti-His monoclonal antibody (His). 

Phrase: "the lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "immunoprecipitated (IP) with a control monoclonal antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0243148:control [Qualitative Concept]
   753   C0746619:monoclonal [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "an anti-"

Phrase: "His monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "("

Phrase: "His"

Phrase: ")."
Processing 00000000.tx.188: Following separation by SDS-polyacrylamide gel electrophoresis and transfer to polyvinylidene difluoride membranes, the membranes were immunoblotted with an anti--catenin monoclonal antibody to detect association with endogenous -catenin. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "separation by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]
   716   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]

Phrase: "and"

Phrase: "transfer to polyvinylidene difluoride membranes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunoblotted with an anti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "--"

Phrase: "catenin monoclonal antibody to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "association with endogenous -catenin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
Processing 00000000.tx.189: A, Western blot of -catenin coimmunoprecipitated with PS1, wild type, and with GSK-3 PS1 mutants (upper) and of exogenous PS1 expression (lower). 

Phrase: "A,"

Phrase: "Western blot of -catenin"

Phrase: "coimmunoprecipitated with PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "wild type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and with GSK-3 PS1 mutants"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596988:mutants [Cell or Molecular Dysfunction]
   744   C1418985:PS1 [Gene or Genome]
   744   C1515981:And [Idea or Concept]
   744   C2986918:PS1 [Gene or Genome]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: ")"

Phrase: "and of exogenous PS1 expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1515981:And [Idea or Concept]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "(lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")."
Processing 00000000.tx.190: B, Western blot of -catenin coimmunoprecipitated with wild type and PS1-(S353A) or PS1-(S357A). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western blot of -catenin"

Phrase: "coimmunoprecipitated with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(S353A"

Phrase: ")"

Phrase: "or"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(S357A"

Phrase: ")."
Processing 00000000.tx.191: C, Western blot of -catenin coimmunoprecipitated with wild type and FAD PS1. 

Phrase: "C,"

Phrase: "Western blot of -catenin"

Phrase: "coimmunoprecipitated with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "FAD PS1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
Processing 00000000.tx.192: Recent reports have suggested that PS1-FAD mutant effects may be attributed to an altered association between PS1-FAD and -catenin (7, 13-15). 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PS1-FAD mutant effects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1832428:Familial form [Finding]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to an altered association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0004083:Association [Mental Process]
   760   C0392747:Altered [Functional Concept]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "between PS1-FAD"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   868   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   861   C0277558:Familial disease [Disease or Syndrome]
   825 E C0344339:family disease [Finding]
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   818   C1832428:Familial form [Finding]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0015576:familial [Family Group]
   795   C0205103:Between [Spatial Concept]
   795   C0241888:Familial [Functional Concept]
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0348078:Form [Qualitative Concept]
   795   C0376315:Form [Manufactured Object]
   795   C1418985:PS1 [Gene or Genome]
   795   C1522492:Form [Functional Concept]
   795   C2986918:PS1 [Gene or Genome]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]
   724 E C1704727:Family [Conceptual Entity]

Phrase: "and -"

Phrase: "catenin"

Phrase: "(7,"

Phrase: "13-15"

Phrase: ")."
Processing 00000000.tx.193: We examined the association between PS1-FAD mutants and endogenous -catenin. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the association between PS1-FAD mutants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0544093:Association, familial [Finding]
   757   C1511978:Disease Association [Temporal Concept]
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "endogenous -catenin."
Processing 00000000.tx.194: The results shown in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.195: 3C clearly demonstrate that equivalent quantities of endogenous -catenin and PS1 could be coimmunoprecipitated from 293HEK cells transiently transfected with PS1-WT or PS1-FAD (M146V and E280G) expression constructs. 

Phrase: "3C clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "demonstrate"

Phrase: "that equivalent quantities of endogenous -catenin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1265611:QUANTITIES [Quantitative Concept]
   719 E C1554108:Quantity [Intellectual Product]
   719 E C1561573:Quantity [Intellectual Product]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "coimmunoprecipitated from 293HEK cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS1-WT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS1-FAD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(M146V"

Phrase: "and"

Phrase: "E280G"

Phrase: ")"

Phrase: "expression constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.196: Thus, PS1-FAD mutations do not appear to influence binding to -catenin. 

Phrase: "Thus,"

Phrase: "PS1-FAD mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "binding to -catenin."
Processing 00000000.tx.197: The Ser353, Ser357 PS1 Motif Can Be Phosphorylated by GSK-3-- To directly demonstrate that the Ser353, Ser357 site is recognized by GSK-3, we carried out in vitro kinase studies. 

Phrase: "The Ser353,"

Phrase: "Ser357 PS1 Motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "Can"

Phrase: "Be"

Phrase: "Phosphorylated by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "To directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the Ser353,"

Phrase: "Ser357 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "recognized by GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in vitro kinase studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   872   C0681828:in vitro study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]
Processing 00000000.tx.198: A synthetic peptide with the Ser353, Ser357 motif centered within the sequence was assessed as a substrate for purified recombinant GSK-3. 

Phrase: "A synthetic peptide with the Ser353,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1883254:synthetic [Activity]

Phrase: "Ser357 motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "centered within the sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0205099:centered [Spatial Concept]
   770   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "assessed as a substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516048:Assessed [Activity]
   770   C1710236:Substrate [Manufactured Object]

Phrase: "for purified recombinant GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.199: An identical peptide in which Ser353 and Ser357 were replaced with alanine residues served as a control substrate. 

Phrase: "An identical peptide in which Ser353"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Ser357"

Phrase: "were"

Phrase: "replaced with alanine residues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "served as a control substrate."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1710236:Substrate [Manufactured Object]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.200: Phosphorylation was observed with only the Ser353, Ser357-containing substrate following incubation (Fig. 4A). 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "observed with only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "the Ser353,"

Phrase: "Ser357-containing substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.201: Insignificant phosphorylation was seen when the serine residues were replaced with alanine residues. 

Phrase: "Insignificant phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "the serine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "replaced with alanine residues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.202: This result argues against phosphorylation at the threonine 354site, a residue shared by both peptides. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "argues against phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at the threonine 354site,"

Phrase: "a residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "shared by both peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0237876:shared [Social Behavior]
   770   C1522138:Shared [Functional Concept]
Processing 00000000.tx.203: The selectivity of Ser353, Ser357 phosphorylation by GSK-3 was determined. 

Phrase: "The selectivity of Ser353,"

Phrase: "Ser357 phosphorylation by GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.204: We compared levels of phosphate incorporation onto the Ser353, Ser357 peptide by GSK-3 against four other serine/threonine kinases: p38, p38, protein kinase C, and casein kinase II. 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "levels of phosphate incorporation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   819   C0428304:levels phosphate [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "onto the Ser353,"

Phrase: "Ser357 peptide by GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0030952:peptide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "against four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "other serine/threonine kinases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   988 E C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "p38,"

Phrase: "p38,"

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "casein kinase II."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.205: Only GSK-3 was able to phosphorylate this site (Fig. 4B). 

Phrase: "Only GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.206: Therefore, it appears that phosphorylation of the Ser353, Ser357 motif is selective for GSK-3. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that phosphorylation of the Ser353,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "Ser357 motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "selective for GSK-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.207: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.208: 4.  

Phrase: "4."
Processing 00000000.tx.209: In vitro and in vivo phosphorylation of PS1 by GSK-3. 

Phrase: "In vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.210: A, in vitro kinase reactions were performed using synthetic peptides corresponding to either the wild type Ser353, Ser357 GSK-3 motif (NH2- GPHRSTPESRAAV-COOH) or mutated (NH2-GPHRATPEARAAV-COOH) and GSK3. 

Phrase: "A,"

Phrase: "in vitro kinase reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "corresponding to either"

Phrase: "the wild type Ser353,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "Ser357 GSK-3 motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514562:Motif [Amino Acid Sequence]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(NH2- GPHRSTPESRAAV-COOH"

Phrase: ")"

Phrase: "or"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(NH2-GPHRATPEARAAV-COOH"

Phrase: ")"

Phrase: "and"

Phrase: "GSK3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.211: Reactions, run in duplicate, were incubated for 0or 60min, after which incorporation of 32PO3 was monitored. 

Phrase: "Reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "run in duplicate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205173:Duplicate [Functional Concept]
   827   C3539942:Duplicate [Intellectual Product]
   734   C3274438:RUN-IN [Temporal Concept]

Phrase: "were"

Phrase: "incubated for 0or 60min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "after"

Phrase: "which incorporation of 32PO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.212: B, in vitro reactions to address selectivity were carried out with wild type peptide and 10units of kinase for 60min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in vitro reactions to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "selectivity"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with wild type peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0332307:Type [Qualitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C0849355:Out [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "10units of kinase"

Phrase: "for 60min."
Processing 00000000.tx.213: GSK-3, p38, p38, protein kinase C, and casein kinase II were tested on the PS1 wild type substrate and on their cognate substrates (not shown). 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "p38,"

Phrase: "p38,"

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "casein kinase II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "tested on the PS1 wild type substrate"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C1883559:Wild Type [Organism Attribute]
   757   C0449570:Test type [Intellectual Product]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0392366:tested [Intellectual Product]
   748   C0445392:Wild [Intellectual Product]
   748   C1418985:PS1 [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
   748   C1710236:Substrate [Manufactured Object]
   748   C2986918:PS1 [Gene or Genome]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "and on their cognate substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   726   C1710236:Substrate [Manufactured Object]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.214: C, immunoprecipitation of PS1 CTF phosphorylated in vivo. 

Phrase: "C,"

Phrase: "immunoprecipitation of PS1 CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "phosphorylated"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.215: Phosphorylation was assessed by [32P]orthophosphate-labeling 293HEK cells transiently expressing wild type (WT) PS1; 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "assessed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1516048:Assessed [Activity]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate-labeling 293HEK cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild type (WT) PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.216: PS1 carrying Ser353 and Ser357 mutations; 

Phrase: "PS1 carrying Ser353"

Phrase: "and"

Phrase: "Ser357 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.217: or PS1 carrying Thr320, Ser324, Ser353, Ser357, Ser397, and Ser401 GSK-3 site mutations. 

Phrase: "or"

Phrase: "PS1 carrying Thr320,"

Phrase: "Ser324,"

Phrase: "Ser353,"

Phrase: "Ser357,"

Phrase: "Ser397,"

Phrase: "and"

Phrase: "Ser401 GSK-3 site mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.218: PS1 CTF in cell lysates was purified by nickel affinity chromatography and immunoprecipitation. 

Phrase: "PS1 CTF in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   801   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "purified by nickel affinity chromatography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0008551:Chromatography, Affinity [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1998793:Purified [Functional Concept]
   760   C2348274:Nickel [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.219: Wild type PS1 was dephosphorylated with alkaline phosphatase (PS1 WT phosphatase). 

Phrase: "Wild type PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "was"

Phrase: "dephosphorylated with alkaline phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1149880:phosphatase [Molecular Function]
   770   C1979842:Alkaline [Qualitative Concept]

Phrase: "(PS1 WT phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]

Phrase: ")."
Processing 00000000.tx.220: D, Western blot of wild type and GSK-3 mutant PS1 CTF expressed in 293HEK cells detected by anti-His antibody. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Western blot of wild type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "GSK-3 mutant PS1 CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C1707271:C-Terminal [Amino Acid Sequence]
   791   C0205088:Terminal [Temporal Concept]
   791   C0332255:fragment [Functional Concept]
   791   C1705314:Terminal [Manufactured Object]
   791   C1705315:Terminal [Spatial Concept]
   791   C1708096:Fragment [Qualitative Concept]

Phrase: "expressed in 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "detected by anti-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "His antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.221: We next evaluated the in vivo phosphorylated state of wild type PS1, PS1 mutated at the Ser353, Ser357 GSK-3 site, and PS1 mutated at all three GSK-3 consensus sites. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the in vivo phosphorylated state of wild type PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "mutated at the Ser353,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   737 E C1513776:Mutate [Genetic Function]

Phrase: "Ser357 GSK-3 site,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205145:Site [Spatial Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "mutated at all three GSK-3 consensus sites."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205145:Sites [Spatial Concept]
   739   C0205449:Three [Quantitative Concept]
   739   C0376298:Consensus [Social Behavior]
   739   C1705285:Mutated [Cell or Molecular Dysfunction]
   706 E C1513776:Mutate [Genetic Function]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.222: Wild type and mutant PS1 DNA were transiently expressed in 293HEK cells, during which time protein was radiolabeled with [32P]orthophosphate. 

Phrase: "Wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant PS1 DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transiently"

Phrase: "expressed in 293HEK cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "during which time protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "radiolabeled with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1527121:Radiolabeled [Qualitative Concept]
   799 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]
Processing 00000000.tx.223: Each PS1 CTF was purified by virtue of a His epitope added to the C terminus using nickel affinity chromatography and immunoprecipitation with anti-His antibody. 

Phrase: "Each PS1 CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "purified by virtue of a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042764:Virtue [Idea or Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "His epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "added to the C terminus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nickel affinity chromatography"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0008551:Chromatography, Affinity [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "immunoprecipitation with anti-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "His antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.224: Wild type PS1 expression generated a phosphorylated CTF that was sensitive to alkaline phosphatase (Fig. 4C). 

Phrase: "Wild type PS1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a phosphorylated CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "sensitive to alkaline phosphatase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: The phosphorylated wild type CTF migrated slightly slower upon gel electrophoresis as expected (Fig. 4, C and D). 

Phrase: "The phosphorylated wild type CTF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0445393:Wild C [Intellectual Product]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "slightly slower upon gel electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0439834:Slow [Qualitative Concept]

Phrase: "as expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.226: In contrast to the phosphorylated CTF observed with wild type PS1 expression, only trace amounts of phosphorylated CTF were produced by the Ser353, Ser357 mutant, and virtually no phosphorylated CTF was seen with PS1 mutated at all three GSK-3 motifs (Fig. 4C). 

Phrase: "In contrast to the phosphorylated CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "observed with wild type PS1 expression,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418985:PS1 [Gene or Genome]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "only trace amounts of phosphorylated CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0442822:trace amount [Quantitative Concept]
   744   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "produced by the Ser353,"

Phrase: "Ser357 mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "virtually"

Phrase: "no phosphorylated CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "seen with PS1"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205397:Seen [Qualitative Concept]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "mutated at all three GSK-3 motifs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205449:Three [Quantitative Concept]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   708 E C1513776:Mutate [Genetic Function]
   708   C1514562:Motif [Amino Acid Sequence]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.227: Wild type and both mutants as shown by Western blot analysis (Fig. 4D) expressed approximately equivalent amounts of CTF. 

Phrase: "Wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "both mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "as"

Phrase: "shown by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")"

Phrase: "expressed"

Phrase: "approximately equivalent amounts of CTF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.228: The PS1 mutant harboring mutations at all three GSK-3 motifs was expressed at slightly higher levels but was not phosphorylated. 

Phrase: "The PS1 mutant harboring mutations at all three GSK-3 motifs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   735   C0026882:Mutations [Genetic Function]
   702 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "expressed at slightly higher levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0441889:Levels [Qualitative Concept]
   760   C0750482:Slightly [Idea or Concept]
   726   C0205250:High [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726   C1299351:High [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726   C2700149:HIGH [Intellectual Product]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "phosphorylated."
Processing 00000000.tx.229: These data indicate that PS1 is phosphorylated at the GSK-3 sites in vivo. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated at the GSK-3 sites"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.230: Disruption of PS1/-Catenin Interaction Does Not Affect -Catenin Stability or Tcf/Lef-mediated Signaling-- In response to activation of the Wnt signaling pathway, -catenin stability is increased, enabling translocation to the nucleus, where it regulates the transcription of Wnt-responsive genes. 

Phrase: "Disruption of PS1/-Catenin Interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Catenin Stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "or"

Phrase: "Tcf/Lef-mediated Signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "-"

Phrase: "-"

Phrase: "In response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the Wnt signaling pathway, -"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1520113:Wnt Signaling Pathway [Molecular Function]
           Wnt Pathway
  1000   C2984336:Wnt signaling pathway [Functional Concept]
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   734   C2984359:Wnt signaling [Functional Concept]

Phrase: "catenin stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "translocation to the nucleus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]

Phrase: "where"

Phrase: "it"

Phrase: "regulates"

Phrase: "the transcription of Wnt-responsive genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0040649:genes transcription [Genetic Function]
           Transcription
Processing 00000000.tx.231: Several recent conflicting reports have suggested that the effect of wild type and FAD-PS1 on -catenin signaling arise from either disruption of processes affecting cytoplasmic accumulation of -catenin (13) or processes involving nuclear translocation of -catenin (16). 

Phrase: "Several recent conflicting reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0684224:Reports [Intellectual Product]
   812   C0700287:reports [Health Care Activity]
   779 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of wild type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "FAD-PS1 on -catenin signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1832428:Familial form [Finding]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "arise from either disruption of processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332453:Disruption [Functional Concept]
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "cytoplasmic accumulation of -catenin"

Phrase: "(13"

Phrase: ")"

Phrase: "or"

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "nuclear translocation of -catenin"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.232: To assess the effect of disrupting PS1 and -catenin association on -catenin signaling, we examined endogenous -catenin levels by Western blot analysis of cytosolic and nuclear fractions from 293HEK cells transiently transfected with either wild type PS1, FAD-PS1, or the GSK-3 mutant PS1-(S353A,S357A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of disrupting PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and -"

Phrase: "catenin association on -catenin signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "endogenous -catenin levels by Western blot analysis of cytosolic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "nuclear fractions from 293HEK cells transiently"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0805525:Cell fractions [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "transfected with either wild type PS1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418985:PS1 [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "FAD-PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "the GSK-3 mutant PS1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1418985:PS1 [Gene or Genome]
   799   C2986918:PS1 [Gene or Genome]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")."
Processing 00000000.tx.233: No apparent differences were observed between the basal levels of endogenous cytosolic or nuclear -catenin in untransfected, wild type, or FAD-PS1-expressing cultures (Fig. 5, A and B). 

Phrase: "No apparent differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed between the basal levels of endogenous cytosolic"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0205112:Basal [Spatial Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1383501:Cytosolic [Cell Component]
   744   C1441672:Observed [Functional Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "nuclear -catenin in untransfected, wild type,"

Phrase: "or"

Phrase: "FAD-PS1-expressing cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1832428:Familial form [Finding]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.234: In 293HEK cells transfected with the PS1-(S353A,S357A) mutant, which disrupts the association between PS1 and -catenin, both cytosolic and nuclear levels of -catenin were similar to those of wild type PS1-expressing cultures (Fig. 5, A and B). 

Phrase: "In 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: "mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin,"

Phrase: "both cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "nuclear levels of -catenin"

Phrase: "were"

Phrase: "similar to those of wild type PS1-expressing cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.235: This conclusion is most apparent when -catenin levels from individual experiments are normalized to GSK-3 (Fig. 5, histograms). 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "most apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]

Phrase: "when -"

Phrase: "catenin levels from individual experiments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "normalized to GSK-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1882115:Normalized [Research Activity]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348974:Histogram [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.236: These results demonstrate that disruption of the association between PS1 and -catenin has no apparent adverse affect on cytosolic levels of -catenin or on nuclear localization of -catenin. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that disruption of the association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "has"

Phrase: "no apparent adverse"

Phrase: "affect on cytosolic levels of -catenin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0001721:Affect [Mental Process]
   753   C0441889:Levels [Qualitative Concept]
   753   C1383501:Cytosolic [Cell Component]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "or on nuclear localization of -catenin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0475264:Localisation [Functional Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.237: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.238: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.239: PS1/-catenin association in regulating -catenin stability and Tcf/Lef-mediated signaling. 

Phrase: "PS1/-catenin association in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "regulating -"

Phrase: "catenin stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "Tcf/Lef-mediated signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.240: Subconfluent cultures of 293HEK cells were transiently transfected with the indicated wild type, FAD, or site-directed GSK-3 mutants of PS1. 

Phrase: "Subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated wild type, FAD,"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   772   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   770   C3463805:Type of Form [Intellectual Product]
           form type
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   756   C1832428:Familial form [Finding]
   756   C1883559:Wild Type [Organism Attribute]
   754   C0277558:Familial disease [Disease or Syndrome]
   754   C0457464:disease type [Intellectual Product]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0015576:familial [Family Group]
   738   C0241888:Familial [Functional Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0445392:Wild [Intellectual Product]
   738   C1444656:Indicated [Finding]
   738   C1522492:Form [Functional Concept]
   738   C1547052:*Type [Quantitative Concept]
   718 E C0344339:disease family [Finding]

Phrase: "or"

Phrase: "site-directed GSK-3 mutants of PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.241: Twenty-four hours post-transfection, cytosolic (A) and nuclear (B) extracts were prepared, and the levels of endogenous -catenin were determined by immunoblotting with an anti--catenin monoclonal antibody. 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "(A)"

Phrase: "and"

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(B) extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the levels of endogenous -catenin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with an anti"

Phrase: "--"

Phrase: "catenin monoclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]
Processing 00000000.tx.242: Data presented in the histogram is representative of three independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented in the histogram"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C2348974:Histogram [Manufactured Object]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "is"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.243: C, pulse-chase analysis of -catenin degradation. 

Phrase: "C,"

Phrase: "pulse-chase analysis of -catenin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0243125:degradation [Functional Concept]
   799   C0699900:Degradation [Organism Function]
Processing 00000000.tx.244: Subconfluent cultures of 293HEK cells were transiently transfected with the indicated wild type, FAD, or site-directed GSK-3 mutants of PS1. 

Phrase: "Subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated wild type, FAD,"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   772   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   770   C3463805:Type of Form [Intellectual Product]
           form type
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   756   C1832428:Familial form [Finding]
   756   C1883559:Wild Type [Organism Attribute]
   754   C0277558:Familial disease [Disease or Syndrome]
   754   C0457464:disease type [Intellectual Product]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0015576:familial [Family Group]
   738   C0241888:Familial [Functional Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0445392:Wild [Intellectual Product]
   738   C1444656:Indicated [Finding]
   738   C1522492:Form [Functional Concept]
   738   C1547052:*Type [Quantitative Concept]
   718 E C0344339:disease family [Finding]

Phrase: "or"

Phrase: "site-directed GSK-3 mutants of PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.245: Twenty-four hours post-transfection, cells were pulse-chase-labeled with [35S]methionine/cysteine and analyzed by immunoprecipitation of endogenous -catenin with an anti--catenin monoclonal antibody. 

Phrase: "Twenty-four hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pulse-chase-"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "analyzed by immunoprecipitation of endogenous -catenin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021069:Immunoprecipitation [Laboratory Procedure]
   753   C0205227:Endogenous [Functional Concept]
   753   C0936012:Analyzed [Research Activity]

Phrase: "with an anti"

Phrase: "--"

Phrase: "catenin monoclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]
Processing 00000000.tx.246: D, subconfluent cultures of 293HEK cells were transiently transfected with 100ng of the pTOPFLASH-luciferase reporter gene plasmid along with 0.5g of Wnt-1 and the indicated wild type, FAD, or site-directed mutants of PS1. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with 100ng of the pTOPFLASH-luciferase reporter gene plasmid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0206414:Reporter Gene [Gene or Genome]
   757   C1334435:Luciferase Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0335038:Reporter [Professional or Occupational Group]
   739   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   739   C1705915:Reporter [Conceptual Entity]
   739   C1709908:Reporter [Group]

Phrase: "along with 0.5g"

Phrase: "of Wnt-1"

Phrase: "and"

Phrase: "the indicated wild type, FAD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C3463805:Type of Form [Intellectual Product]
           form type
   764   C1832428:Familial form [Finding]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "site-directed mutants of PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.247: In all experiments, cells were harvested 24h post-transfection, and levels of luciferase activity were determined according to the manufacturer's instructions (Promega). 

Phrase: "In all experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24h post-transfection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456696:/24h [Temporal Concept]
   827   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "levels of luciferase activity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   819   C0683317:activity levels [Finding]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined according to the manufacturer's instructions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.248: Results are the meanS.D. of a representative experiment performed in duplicate normalized for -galactosidase expression. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of a representative experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "normalized for -galactosidase expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1882115:Normalized [Research Activity]
Processing 00000000.tx.249: E, -catenin induction of the Wnt signaling cascade. 

Phrase: "E, -"

Phrase: "catenin induction of the Wnt signaling cascade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1519308:Signal Induction [Molecular Function]
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.250: -Catenin (0.75g) was coexpressed with pTOPFLASH-luciferase and PS1 plasmids in 293HEK cells using an identical procedure to that described above in D. 

Phrase: "-Catenin"

Phrase: "(0.75g"

Phrase: ")"

Phrase: "was"

Phrase: "coexpressed with pTOPFLASH-luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "PS1 plasmids in 293HEK cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an identical procedure to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1948041:Procedure [Therapeutic or Preventive Procedure]
   770   C2700391:Procedure [Activity]
   770   C3274430:PROCEDURE [Health Care Activity]
   770   C3538935:Procedure [Idea or Concept]
   770   C3539779:Procedure [Intellectual Product]

Phrase: "that described above in D."
Processing 00000000.tx.251: As mentioned earlier, the regulation of -catenin stability is a crucial control point in Wnt-mediated signaling pathways. 

Phrase: "As"

Phrase: "mentioned"

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "the regulation of -catenin stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0205360:Stability [Qualitative Concept]
   812   C2347098:Stability [Qualitative Concept]
   741 E C1547311:Stable [Intellectual Product]

Phrase: "is"

Phrase: "a crucial control point in Wnt-mediated signaling pathways."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C2924612:A point [Body Location or Region]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1552961:Point [Quantitative Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2347617:point [Quantitative Concept]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.252: To determine whether dissociation of the interaction between PS1 and -catenin affects the function of -catenin by altering its stability, we assessed -catenin degradation by pulse-chase analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "dissociation of the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the function of -catenin by altering"

Phrase: "its stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "we"

Phrase: "assessed -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "catenin degradation by pulse-chase analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.253: Subconfluent 293HEK cells were transiently transfected with an expression construct that encoded His epitope-tagged versions of either wild type PS1, FAD PS1, or GSK-3 mutant PS1-(S353A,S357A) or PS1-(T320R,S324A). 

Phrase: "Subconfluent 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with an expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "that"

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "His epitope-tagged versions of either wild type PS1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0333052:versions [Functional Concept]
   708 E C2607870:Version [Spatial Concept]

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "GSK-3 mutant PS1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1418985:PS1 [Gene or Genome]
   799   C2986918:PS1 [Gene or Genome]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: "or"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(T320R,"

Phrase: "S324A"

Phrase: ")."
Processing 00000000.tx.254: Endogenous -catenin was degraded at a similar rate in cells transfected with vector alone, wild type PS1, or FAD PS1, which contains the E280G mutation associated with FAD (Fig. 5C). 

Phrase: "Endogenous -catenin"

Phrase: "was"

Phrase: "degraded at a similar rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with vector alone, wild type PS1,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205171:Alone [Quantitative Concept]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0439044:alone [Finding]
   748   C0442335:Vector [Spatial Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0679994:alone [Group Attribute]
   748   C1418985:PS1 [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the E280G mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with FAD"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   804   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1832428:Familial form [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
   738 E C0344339:disease family [Finding]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.255: Endogenous -catenin in cells expressing PS1-(S353A,S357A) which is unable to associate with -catenin had an equivalent half-life. 

Phrase: "Endogenous -catenin in cells"

Phrase: "expressing"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: "which"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "associate with -catenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "had"

Phrase: "an equivalent half-life."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0018517:Half-Life [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   827   C2825407:Half [Quantitative Concept]
   743 E C0595998:lives [Finding]
Processing 00000000.tx.256: Thus, disruption of the binding between PS1 and -catenin does not affect the stability of -catenin. 

Phrase: "Thus,"

Phrase: "disruption of the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "between PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the stability of -catenin."
Processing 00000000.tx.257: To directly assess the role of PS1 and its association with -catenin in a -catenin signaling cascade, we determined the effects of wild type PS1, FAD PS1, and several PS1 GSK-3 mutants in a Tcf-luciferase reporter assay. 

Phrase: "To directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the role of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its association with -catenin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in a -catenin signaling cascade,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2611812:signaling cascade [Cell Function]
   812   C1707310:Cascade [Manufactured Object]

Phrase: "we"

Phrase: "determined"

Phrase: "the effects of wild type PS1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "several PS1 GSK-3 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0596988:mutants [Cell or Molecular Dysfunction]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in a Tcf-luciferase reporter assay."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C0335038:Reporter [Professional or Occupational Group]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   812   C1705915:Reporter [Conceptual Entity]
   812   C1709908:Reporter [Group]
Processing 00000000.tx.258: In the prevailing model, following the initiation of a Wnt signaling cascade, GSK-3 is inhibited, leading to decreased phosphorylation and accumulation of cytosolic -catenin. 

Phrase: "In the prevailing model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the initiation of a Wnt signaling cascade,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0589507:Initiation [Mental Process]
   748   C1158830:Initiation [Genetic Function]
   748   C1704686:Initiation [Functional Concept]

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "leading to decreased phosphorylation"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "accumulation of cytosolic -catenin."
Processing 00000000.tx.259: This allows -catenin to translocate to the nucleus and regulate gene expression via interaction with Tcf/Lef transcription factors. 

Phrase: "This"

Phrase: "allows -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "catenin to"

Phrase: "translocate to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "regulate"

Phrase: "gene expression via interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0017262:Gene Expression [Genetic Function]
   819   C0596610:gene interaction [Genetic Function]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with Tcf/Lef transcription factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1566664:LEF Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           TCF Transcription Factors
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.260: To measure PS1 activity or involvement, we cotransfected 293HEK cells with an expression vector encoding Wnt-1 together with wild type PS1, FAD PS1, GSK-3 mutant PS1-(S353A, S357A), or PS1-(T320R,S324A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "PS1 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "involvement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involvement [Functional Concept]

Phrase: "we"

Phrase: "cotransfected"

Phrase: "293HEK cells with an expression vector encoding Wnt-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "together with wild type PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "GSK-3 mutant PS1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1418985:PS1 [Gene or Genome]
   799   C2986918:PS1 [Gene or Genome]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(T320R,"

Phrase: "S324A"

Phrase: ")."
Processing 00000000.tx.261: Upon expression, Wnt-1 acts in an autocrine/paracrine fashion to activate its receptor, frizzled, on 293HEK and to initiate the -catenin signaling cascade (25). 

Phrase: "Upon expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Wnt-1 acts in an autocrine/paracrine fashion to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "its receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "frizzled,"

Phrase: "on 293HEK"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the -catenin signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.262: Expression of Wnt-1 alone induced Tcf-mediated luciferase activity in a dose-dependent manner (data not shown) with maximum induction of luciferase activity being 6-8-fold compared with control vector (Fig. 5D). 

Phrase: "Expression of Wnt-1 alone induced Tcf-mediated luciferase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "with maximum induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "being"

Phrase: "6-8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "compared with control vector"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0031249:control vector [Occupational Activity]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0243148:control [Qualitative Concept]
   770   C0442335:Vector [Spatial Concept]
   770   C1550141:Control [Substance]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.263: Cotransfection of Wnt-1 with wild type PS1, FAD PS1, or control PS1 GSK-3 mutant (T320A,S324A) did not significantly affect Tcf-mediated luciferase activity (Fig. 5D). 

Phrase: "Cotransfection of Wnt-1"

Phrase: "with wild type PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "control PS1 GSK-3 mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0596988:Mutant [Cell or Molecular Dysfunction]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(T320A,"

Phrase: "S324A"

Phrase: ")"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Tcf-mediated luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1151115:luciferase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.264: Similarly, coexpression of Wnt-1 with PS1-(S353A,S357A) or FAD PS1 (S353A,S357A), which fail to associate with -catenin, had little effect on Wnt-1-induced Tcf-luciferase activity (Fig. 5D). 

Phrase: "Similarly,"

Phrase: "coexpression of Wnt-1"

Phrase: "with PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: "or"

Phrase: "FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with -catenin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "had"

Phrase: "little effect on Wnt-1-induced Tcf-luciferase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.265: Identical results were obtained when cells were cotransfected with -catenin and the same PS1 constructs (Fig. 5E). 

Phrase: "Identical results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cotransfected with -catenin"

Phrase: "and"

Phrase: "the same PS1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "(Fig. 5E"

Phrase: ")."
Processing 00000000.tx.266: Taken together, these results clearly demonstrate that dissociation of PS1 and -catenin binding has no significant effect on -catenin stability or on Wnt-1- or -catenin-mediated gene expression. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that dissociation of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "catenin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "has"

Phrase: "no significant effect on -catenin stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0205360:Stability [Qualitative Concept]
   804   C2347098:Stability [Qualitative Concept]
   733 E C1547311:Stable [Intellectual Product]

Phrase: "or on Wnt-1- or -catenin-mediated gene expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0017262:Gene Expression [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.267: Disruption of PS1/Catenin Binding Does Not Influence PS1-FAD-increased Susceptibility to Apoptosis-- One of the pathological characteristics of PS-associated FAD is an increased susceptibility of neuronal cells to inducers of apoptosis (2-4). 

Phrase: "Disruption of PS1/Catenin Binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Influence"

Phrase: "PS1-FAD-increased Susceptibility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1832428:Familial form [Finding]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "to Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "--"

Phrase: "One of the pathological characteristics of PS-associated FAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "an increased susceptibility of neuronal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to inducers"

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.268: We next determined whether disruption of PS1 and -catenin binding affected cell viability by altering cell vulnerability to apoptosis. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "whether"

Phrase: "disruption of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332453:Disruption [Functional Concept]

Phrase: "and -"

Phrase: "catenin binding affected cell viability by altering cell vulnerability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0007620:Cell Viability [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0443348:viability [Qualitative Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "to apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.269: Subconfluent cultures of HEK293 cells were cotransfected with green fluorescent protein and wild type PS1, FAD PS1, or PS1 GSK-3 mutants (Fig. 6A). 

Phrase: "Subconfluent cultures of HEK293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "cotransfected with green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]

Phrase: "and"

Phrase: "wild type PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "FAD PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "PS1 GSK-3 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.270: Following treatment with etoposide, all cell cultures displayed a progressive increase in the number of apoptotic cells (Fig. 6A). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with etoposide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "all cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a progressive increase in the number of apoptotic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.271: Cells treated with etoposide exhibited characteristic morphologies of cells undergoing apoptosis, becoming rounded and condensed and detaching from the culture dish (Fig. 6B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with etoposide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "characteristic morphologies of cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   786   C0243091:cell morphology [Qualitative Concept]
   786   C1521816:Cell morphology [Clinical Attribute]
   786   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   737   C0332437:Morphology [Qualitative Concept]
   737   C0543482:morphology [Spatial Concept]
   737   C0700329:Morphology, NOS [Finding]
   737   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "undergoing"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "becoming"

Phrase: "rounded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]

Phrase: "and"

Phrase: "condensed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1155631:Condensed [Cell Function]

Phrase: "and"

Phrase: "detaching from the culture dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0687118:detaching [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.272: Consistent with previous reports, cells expressing PS1-FAD mutants showed a significant enhancement in their susceptibility to etoposide, with increased numbers of apoptotic cells present at 12h after exposure to etoposide (Fig. 6A). 

Phrase: "Consistent with previous reports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS1-FAD mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant enhancement in their susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "to etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "with increased numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "present at 12h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C0456695:/12h [Temporal Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.273: Expression of either wild type PS1-(S353A,S357A) or FAD PS1-(S353A,S357A), which no longer associate with -catenin, did not affect cell susceptibility to apoptosis. 

Phrase: "Expression of either wild type PS1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: "or"

Phrase: "FAD PS1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(S353A,"

Phrase: "S357A"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "associate with -catenin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell susceptibility to apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.274: Thus, dissociation of the binding between -catenin and either wild type PS1 or FAD PS1 does not alter cell vulnerability to apoptosis. 

Phrase: "Thus,"

Phrase: "dissociation of the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "between -catenin"

Phrase: "and"

Phrase: "either wild type PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "cell vulnerability to apoptosis."
Processing 00000000.tx.275: View larger version (43K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.276: 6.  

Phrase: "6."
Processing 00000000.tx.277: PS1/-catenin association and cell survival. 

Phrase: "PS1/-catenin association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: A, subconfluent cultures of 293HEK cells were transiently transfected with wild type, FAD or the indicated site-directed mutants of PS1, together with a plasmid encoding green fluorescent protein (pGFP) as an indicator of transfection. 

Phrase: "A,"

Phrase: "subconfluent cultures of 293HEK cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0007585:cells cultures [Laboratory Procedure]
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with wild type, FAD"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   784   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   781   C3463805:Type of Form [Intellectual Product]
           form type
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   764   C1832428:Familial form [Finding]
   764   C1883559:Wild Type [Organism Attribute]
   762   C0277558:Familial disease [Disease or Syndrome]
   762   C0457464:disease type [Intellectual Product]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0241888:Familial [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C0445392:Wild [Intellectual Product]
   742   C1522492:Form [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   726 E C0344339:disease family [Finding]

Phrase: "or"

Phrase: "the indicated site-directed mutants of PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "together with a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "(pGFP"

Phrase: ")"

Phrase: "as an indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
  1000   C1235732:Indicator [Bird]
  1000   C1522602:Indicator [Functional Concept]

Phrase: "of transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.279: Following 24h, cells were either untreated or treated with etoposide (25g/ml) for the indicated time, and the percentage of apoptosis was assessed by morphological evaluation of pGFP-positive cells by fluorescent microscopy. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "either untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "treated with etoposide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(25g/ml) for the indicated time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "the percentage of apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "assessed by morphological evaluation of pGFP-positive cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   770   C0439178:% positive cells [Quantitative Concept]
           % Positive
   750   C2984640:CELL EVALUATION [Functional Concept]
   744   C0007634:Cells [Cell]
   744   C0220825:Evaluation [Functional Concept]
   744   C0543482:morphological [Spatial Concept]
   744   C1261322:Evaluation [Health Care Activity]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C1516048:Assessed [Activity]
   744   C2825490:Positive [Qualitative Concept]
   744   C3282337:Cells [Cell]
   714   C0243091:cell morphology [Qualitative Concept]
   714   C1521816:Cell morphology [Clinical Attribute]
   714   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "by fluorescent microscopy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026022:FLUORESCENT MICROSCOPY [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.280: B, morphology of 293HEK cells under standard culture conditions and cells treated with etoposide. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "morphology of 293HEK cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   802   C0243091:cell morphology [Qualitative Concept]
   802   C1521816:Cell morphology [Clinical Attribute]
   802   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "under standard culture conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with etoposide."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.281: Typical apoptotic features displayed by etoposide-treated cells include cell shrinkage, cytosolic and nuclear condensation, and detachment from the culture vessel (arrow).  

Phrase: "Typical apoptotic features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "displayed by etoposide-treated cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0870432:displayed [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1705417:Display [Manufactured Object]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cell shrinkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "nuclear condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "detachment from the culture vessel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0541879:detachment [Mental Process]
   760   C0595950:Detachment [Pathologic Function]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.282: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES PS1 has been shown to associate with -catenin (5-7); 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with -catenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "(5-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.283: however, the functional significance of this interaction has been unclear. 

Phrase: "however,"

Phrase: "the functional significance of this interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "unclear."
Processing 00000000.tx.284: Likewise, the influence of FAD PS1 on -catenin biology and how this might result in a pathophysiological state has not been fully resolved. 

Phrase: "Likewise,"

Phrase: "the influence of FAD PS1 on -catenin biology"

Phrase: "and"

Phrase: "how"

Phrase: "this"

Phrase: "might"

Phrase: "result in a pathophysiological state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1274040:Result [Functional Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C3148680:State [Geographic Area]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.285: PS1 and -catenin have independently been shown to be associated with cell survival signaling (2, 26, 27). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "have"

Phrase: "independently"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with cell survival signaling"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0007620:Cell Survival [Cell Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0037083:Cell Signaling [Cell Function]
           Signaling
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.286: Consequently, it has been suggested that FAD PS1 causes dysregulation of -catenin such that survival signaling is compromised toward apoptosis. 

Phrase: "Consequently,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "dysregulation of -catenin"

Phrase: "such"

Phrase: "that survival signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "compromised toward apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   756   C2945640:compromise [Finding]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.287: This idea has appeal given the highly reproducible observation that FAD PS1 and FAD PS2 increase cell susceptibility to apoptosis (2-4). 

Phrase: "This idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "has"

Phrase: "appeal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680651:appeal [Governmental or Regulatory Activity]

Phrase: "given"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]

Phrase: "the highly reproducible observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0302523:Observation [Research Activity]
   827   C0700325:observation [Health Care Activity]
   827   C1964257:Observation [Diagnostic Procedure]
   755 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "FAD PS2 increase cell susceptibility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1832428:Familial form [Finding]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.288: Whether FAD PS1 establishes a proapoptotic state by reducing -catenin signaling through destabilizing this protein (13), by impeding its nuclear translocation (16), or by some other mechanism is controversial. 

Phrase: "Whether"

Phrase: "FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "establishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a proapoptotic state by reducing -catenin signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "through destabilizing"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "by impeding"

Phrase: "its nuclear translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518440:Nuclear Translocation [Molecular Function]
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "or by some"

Phrase: "other mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "controversial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]
Processing 00000000.tx.289: In this study, we sought to further define the physical nature of PS1 and -catenin interaction as well as the role of this association in Wnt signaling. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "sought"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "define"

Phrase: "the physical nature of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "and -"

Phrase: "catenin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "as well as"

Phrase: "the role of this association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Wnt signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2984359:Wnt signaling [Functional Concept]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.290: Three key observations can be derived from this work. 

Phrase: "Three key observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0302523:observations [Research Activity]
   827   C0700325:observations [Health Care Activity]
   827   C3244290:observations [Functional Concept]
   793 E C1964257:Observation [Diagnostic Procedure]
   743 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "can"

Phrase: "be"

Phrase: "derived from this work."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043227:Work [Occupational Activity]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.291: First, -catenin binding requires either of two serine residues located in the hydrophilic loop domain of PS1, Ser353 and Ser357. 

Phrase: "First, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "catenin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "requires"

Phrase: "either of two serine residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205448:Two [Quantitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "located in the hydrophilic loop domain of PS1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]
   744   C0475370:Hydrophilic [Qualitative Concept]
   744   C1418985:PS1 [Gene or Genome]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C2986918:PS1 [Gene or Genome]
   744   C3541951:Domain [Intellectual Product]

Phrase: "Ser353"

Phrase: "and"

Phrase: "Ser357."
Processing 00000000.tx.292: Mutating either of these serine residues essentially abolishes the in vivo phosphorylation of PS1 as well as the ability of PS1 to bind to -catenin. 

Phrase: "Mutating either of these serine residues essentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1513776:Mutate [Genetic Function]

Phrase: "abolishes"

Phrase: "the in vivo phosphorylation of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "as well as"

Phrase: "the ability of PS1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to -catenin."
Processing 00000000.tx.293: Furthermore, Ser353 and Ser357 comprise a consensus recognition site for phosphorylation by GSK-3, a serine/threonine kinase known to regulate multiple members of the Wnt signaling complex. 

Phrase: "Furthermore,"

Phrase: "Ser353"

Phrase: "and"

Phrase: "Ser357"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a consensus recognition site for phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1519063:Phosphorylation Site [Amino Acid Sequence]
   753   C0205145:Site [Spatial Concept]
   753   C0524637:Recognition [Mental Process]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "by GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a serine/threonine kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
  1000   C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "multiple members of the Wnt signaling complex."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.294: Second, ablating PS1/-catenin association has no effect on PS1 function as it relates to endoproteolysis and A production. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "ablating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0849355:Removed [Qualitative Concept]
   928   C1883720:Remove [Activity]
   928   C3244314:remove [Functional Concept]

Phrase: "PS1/-catenin association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "no effect on PS1 function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "it"

Phrase: "relates to endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.295: Third, -catenin stability and signaling are unaltered in the absence of PS1 binding. 

Phrase: "Third, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "catenin stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "are"

Phrase: "unaltered in the absence of PS1 binding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709843:Unaltered [Qualitative Concept]
Processing 00000000.tx.296: Moreover, there is no increased propensity toward apoptosis when PS1 is unable to bind efficiently to -catenin. 

Phrase: "Moreover,"

Phrase: "there"

Phrase: "is"

Phrase: "no increased propensity toward apoptosis"

Phrase: "when"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "efficiently to -catenin."
Processing 00000000.tx.297: Since the observation that PS1, but not PS2, binds to -catenin (9), subsequent reports have grossly mapped the domain of -catenin interaction to the hydrophilic loop of PS1 (7, 10). 

Phrase: "Since"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "but"

Phrase: "not PS2,"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to -catenin"

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "subsequent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "grossly"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the domain of -catenin interaction to the hydrophilic loop of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C2936292:Interaction, Hydrophilic [Molecular Function]
   738   C1704675:Interaction [Functional Concept]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.298: Upon alignment of the hydrophilic loop domain of PS1 for several species, we identified a highly conserved sequence containing three GSK-3 consensus phosphorylation sites ((S/T)XXXS) (28). 

Phrase: "Upon alignment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706765:Alignment [Quantitative Concept]

Phrase: "of the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "for several species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a highly conserved sequence containing three GSK-3 consensus phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   787   C0031715:Phosphorylation [Molecular Function]
   787   C0205145:Sites [Spatial Concept]
   787   C1158886:Phosphorylation [Molecular Function]
   766   C1519063:Phosphorylation Site [Amino Acid Sequence]
   754 E C1515974:Site [Body Location or Region]
   754 E C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "("

Phrase: "S/"

Phrase: "T)XXXS"

Phrase: ")"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.299: Two of these consensus motifs are fully conserved across species, and both are absent in PS2. 

Phrase: "Two of these consensus motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "fully"

Phrase: "conserved across species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "both"

Phrase: "are"

Phrase: "absent in PS2."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.300: We anticipated that these GSK-3 site(s) on PS1 might be involved in -catenin association. 

Phrase: "We"

Phrase: "anticipated"

Phrase: "that"

Phrase: "these GSK-3 site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "s) on PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2603362:S' [Clinical Attribute]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -catenin association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.301: Several members of the Wnt signaling complex are regulated by GSK-3, including Axin, APC, and -catenin. 

Phrase: "Several members of the Wnt signaling complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "regulated by GSK-3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Axin,"

Phrase: "APC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "and -"

Phrase: "catenin."
Processing 00000000.tx.302: Phosphorylation of Axin and APC by GSK-3 enhances the efficiency of -catenin binding to these proteins, thereby facilitating the phosphorylation of -catenin by GSK-3 (12, 28). 

Phrase: "Phosphorylation of Axin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "APC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the efficiency of -catenin binding to these proteins,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "thereby"

Phrase: "facilitating"

Phrase: "the phosphorylation of -catenin by GSK-3"

Phrase: "(12,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.303: Therefore, we evaluated the potential role of these three PS1 GSK-3 consensus sites in -catenin binding using site-directed mutagenesis of the serine/threonine residues phosphorylated by GSK-3 within each motif. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the potential role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "of these three PS1 GSK-3 consensus sites in -catenin binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   870   C3270761:glycogen binding [Molecular Function]
   850   C1149289:kinase binding [Molecular Function]
   788   C0243122:binding [Functional Concept]
   788   C1145667:Binding [Activity]
   788   C1167622:Binding [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-directed mutagenesis of the serine/threonine residues"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   767   C2945843:Site of [Qualitative Concept]
   744   C0079866:Mutagenesis [Molecular Function]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
   744   C3146302:Mutagenesis [Laboratory Procedure]
   711   C0439851:Direct [Qualitative Concept]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "phosphorylated by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "within each motif."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.304: Our results identified one GSK-3 motif as critical for PS1/-catenin association. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "one GSK-3 motif as critical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514562:Motif [Amino Acid Sequence]

Phrase: "for PS1/-catenin association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.305: Mutating either Ser353 or Ser357 of this consensus site essentially abolished PS1/-catenin interaction in vivo. 

Phrase: "Mutating either Ser353"

Phrase: "or"

Phrase: "Ser357 of this consensus site essentially abolished PS1/-catenin interaction"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.306: Our result is in agreement with that of Murayama et al. 

Phrase: "Our result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with that"

Phrase: "of Murayama et al."
Processing 00000000.tx.307: (7), who mapped the site to 322-450 of PS1 by deletion mutagenesis and coimmunoprecipitation to analyze association of PS1 and -catenin in vivo. 

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the site to 322-450 of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "by deletion mutagenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511759:Deletion Mutagenesis [Molecular Biology Research Technique]
   861   C0079866:Mutagenesis [Molecular Function]
   861   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "and"

Phrase: "coimmunoprecipitation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "analyze"

Phrase: "association of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.308: Our data are somewhat incompatible with the findings of Saura et al. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "somewhat incompatible with the findings of Saura et al."
Processing 00000000.tx.309: (10), who localized the binding to 331-351 on PS1. 

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "the binding to 331-351"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "on PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.310: In the study by Saura et al., however, portions of the PS1 loop domain were expressed as fusion proteins in E.coli and assessed for -catenin binding in vitro. 

Phrase: "In the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "by Saura et al.,"

Phrase: "however,"

Phrase: "portions of the PS1 loop domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C0449719:Portion [Spatial Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2986918:PS1 [Gene or Genome]
   753   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "expressed as fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "in E.coli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014834:E coli [Bacterium]

Phrase: "and"

Phrase: "assessed for -catenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.311: Thus, PS1 was removed from its normal structural context. 

Phrase: "Thus,"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "removed from its normal structural context."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C0678594:Structural [Spatial Concept]
   753   C0849355:Removed [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719 E C1883720:Remove [Activity]
   719 E C3244314:remove [Functional Concept]
Processing 00000000.tx.312: Because mutating Ser353 and/or Ser357 greatly reduces but does not completely abolish -catenin binding, it is possible that residual binding occurs through minor adjacent sites on PS1, such as at residues 331-351. 

Phrase: "Because"

Phrase: "mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "Ser353"

Phrase: "and/or"

Phrase: "Ser357 greatly"

Phrase: "reduces"

Phrase: "but"

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "abolish -"

Phrase: "catenin binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "occurs through minor adjacent sites"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0026193:Minor [Population Group]
   760   C0205117:Adjacent [Spatial Concept]
   760   C0205145:Sites [Spatial Concept]
   760   C0205165:Minor [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "on PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "such as"

Phrase: "at residues 331-351."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.313: Nonetheless, our data support the primary site of in vivo association with -catenin at this GSK-3 consensus motif in the PS1 loop domain. 

Phrase: "Nonetheless,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the primary site of in vivo association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0449695:Primary site [Spatial Concept]
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "with -catenin"

Phrase: "at this GSK-3 consensus motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514562:Motif [Amino Acid Sequence]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the PS1 loop domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.314: Several independent reports support our conclusion that the Ser353, Ser357 motif on PS1 is phosphorylated by GSK-3. 

Phrase: "Several independent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   793 E C3273238:Report [Intellectual Product]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that"

Phrase: "the Ser353,"

Phrase: "Ser357 motif on PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "phosphorylated by GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.315: The C-terminal loop domain fragment of PS1 in COS cells has been shown to be phosphorylated at serine residues (29, 30). 

Phrase: "The C-terminal loop domain fragment of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "in COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated at serine residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.316: Also, Takashima et al. 

Phrase: "Also,"

Phrase: "Takashima et al."
Processing 00000000.tx.317: (11) demonstrated an in vivo association of PS1 and GSK-3 using coimmunoprecipitation. 

Phrase: "(11"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "an in vivo association of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "coimmunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.318: We were able to demonstrate selective in vitro phosphorylation at the Ser353, Ser357 residues of the consensus motif by GSK-3 but not by four other common serine/threonine kinases. 

Phrase: "We"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "selective in vitro phosphorylation at the Ser353,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "Ser357 residues of the consensus motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not by four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205450:Four [Quantitative Concept]
   790   C1518422:Not [Functional Concept]

Phrase: "other common serine/threonine kinases."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   912 E C1414387:serine/threonine kinase [Gene or Genome]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.319: Importantly, we showed that the Ser353, Ser357 consensus site is phosphorylated in vivo. 

Phrase: "Importantly,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Ser353,"

Phrase: "Ser357 consensus site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.320: Mutations at these residues prevent phosphorylation of PS1 CTF in 293HEK cells. 

Phrase: "Mutations at these residues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "phosphorylation of PS1 CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in 293HEK cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.321: Together, these observations demonstrate the PS1 loop is a substrate for GSK-3 in vivo. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "demonstrate"

Phrase: "the PS1 loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "is"

Phrase: "a substrate for GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.322: The Ser353, Ser357 PS1 point mutants that lack the ability to efficiently bind to -catenin provided us with a means to address the functional significance of this interaction. 

Phrase: "The Ser353,"

Phrase: "Ser357 PS1 point mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the ability to efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to -catenin"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "us with a means to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the functional significance of this interaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.323: Several activities were measured relevant to each of these two proteins. 

Phrase: "Several activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "relevant to each of these two proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.324: With regard to PS1 function, we demonstrated that both A production and endoproteolysis were normal when -catenin binding was prevented. 

Phrase: "With regard to PS1 function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "endoproteolysis"

Phrase: "were"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "when -"

Phrase: "catenin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.325: This result agrees with that of Saura et al. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "agrees with that of Saura et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3641827:Agree [Intellectual Product]
Processing 00000000.tx.326: (10), who deleted the entire loop domain of PS1 and found no effect on endoproteolysis or A generation. 

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "the entire loop domain of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no effect on endoproteolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "A generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.327: More interesting are the results we obtained examining the effects of PS1 dissociation on -catenin stability and cell survival signaling. 

Phrase: "More"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "are"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the effects of PS1 dissociation on -catenin stability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "cell survival signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0037083:Cell Signaling [Cell Function]
           Signaling
   827   C3537152:signaling [Biologic Function]
   734   C0007620:Cell Survival [Cell Function]
Processing 00000000.tx.328: No change in either free cytosolic or nuclear -catenin was observed in the absence of PS1 association. 

Phrase: "No change in either free cytosolic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "nuclear -catenin"

Phrase: "was"

Phrase: "observed in the absence of PS1 association."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0004083:Association [Mental Process]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1418985:PS1 [Gene or Genome]
   748   C1441672:Observed [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.329: Similarly, no significant differences were seen in either cellular compartment between exogenous wild type and FAD PS1. 

Phrase: "Similarly,"

Phrase: "no significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "seen in either cellular compartment"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "between exogenous wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "FAD PS1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
Processing 00000000.tx.330: The effects of PS1 FAD on -catenin levels have been highly controversial, and little consensus exists between numerous investigations including this one (13-16). 

Phrase: "The effects of PS1 FAD on -catenin levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C1280500:effects [Qualitative Concept]
   703 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "highly controversial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]

Phrase: "and"

Phrase: "little consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376298:Consensus [Social Behavior]

Phrase: "exists between numerous investigations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439064:Numerous [Quantitative Concept]
   770   C1261322:Investigations [Health Care Activity]
   770   C2987476:Exist [Conceptual Entity]
   737 E C1552578:investigation [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "this one (13-16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.331: This inconsistency is most likely attributed to the technical difficulties of measuring a small pool of cytosolic -catenin against a background of plasma membrane-associated -catenin that is roughly 10-fold larger (16). 

Phrase: "This inconsistency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0442809:Inconsistent [Qualitative Concept]

Phrase: "is"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "attributed to the technical difficulties of measuring"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0444706:measuring [Qualitative Concept]
   748   C0449770:measuring [Quantitative Concept]
   748   C0449851:Technical [Functional Concept]
   748   C1299586:difficulties [Finding]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "a small pool of cytosolic -catenin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "against a background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "of plasma membrane-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "catenin"

Phrase: "that"

Phrase: "is"

Phrase: "roughly 10-fold larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0443228:larger [Quantitative Concept]
   812   C0549177:Larger [Quantitative Concept]
   812   C1704243:Larger [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.332: Differences in the methods used to assay -catenin might also be a contributing factor to this controversy. 

Phrase: "Differences in the methods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "catenin"

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "a contributing factor to this controversy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.333: The most important issue this study addresses is the role of PS1/-catenin interaction in Wnt signaling. 

Phrase: "The most important"

Phrase: "issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "this study addresses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376649:Addresses [Intellectual Product]
   827 E C1442065:Address [Spatial Concept]

Phrase: "is"

Phrase: "the role of PS1/-catenin interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Wnt signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2984359:Wnt signaling [Functional Concept]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.334: Using the Ser353, Ser357 mutant, we were able to demonstrate normal -catenin signaling when the association between PS1 and -catenin is largely abolished. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Ser353,"

Phrase: "Ser357 mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "normal -catenin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "when"

Phrase: "the association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin"

Phrase: "is"

Phrase: "largely"

Phrase: "abolished."
Processing 00000000.tx.335: This result is supported by an observation of Nishimura et al. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "supported by an observation of Nishimura et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0302523:Observation [Research Activity]
   744   C0700325:observation [Health Care Activity]
   744   C1521721:Supported [Conceptual Entity]
   744   C1964257:Observation [Diagnostic Procedure]
   711 E C0183683:Support [Medical Device]
Processing 00000000.tx.336: (16), who found identical levels of nuclear -catenin in PS1+/+ and PS1/ fibroblasts after exposure to Li+ to induce the Wnt signaling cascade. 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "identical levels of nuclear -catenin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in PS1+/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS1/ fibroblasts after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "to Li+ to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the Wnt signaling cascade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]
   734   C2984359:Wnt signaling [Functional Concept]
Processing 00000000.tx.337: In addition, we found no difference in Wnt signaling between wild type PS1 and PS1 FAD. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in Wnt signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between wild type PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "PS1 FAD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1832428:Familial form [Finding]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
Processing 00000000.tx.338: While Nishimura et al. 

Phrase: "While"

Phrase: "Nishimura et al."
Processing 00000000.tx.339: (16) elegantly showed defective nuclear translocation of -catenin in association with FAD PS1, this study did not include a functional measure for -catenin. 

Phrase: "(16"

Phrase: ")"

Phrase: "elegantly"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "defective nuclear translocation of -catenin in association"

Phrase: "with FAD PS1,"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   868   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   861   C0277558:Familial disease [Disease or Syndrome]
   825 E C0344339:family disease [Finding]
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   818   C1832428:Familial form [Finding]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0015576:familial [Family Group]
   795   C0241888:Familial [Functional Concept]
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332287:With [Qualitative Concept]
   795   C0348078:Form [Qualitative Concept]
   795   C0376315:Form [Manufactured Object]
   795   C1418985:PS1 [Gene or Genome]
   795   C1522492:Form [Functional Concept]
   795   C1705690:With [Intellectual Product]
   795   C2986918:PS1 [Gene or Genome]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]
   724 E C1704727:Family [Conceptual Entity]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a functional measure for -catenin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079809:Measure [Quantitative Concept]
   760   C0242485:Measure [Functional Concept]
Processing 00000000.tx.340: Therefore, it seems possible that while there may exist deficiencies in -catenin trafficking in the FAD PS1 background, sufficient levels of -catenin apparently reach the nuclear compartment to allow for normal induction of Tcf/Lef-mediated transcription. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "seems"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "while"

Phrase: "there"

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "deficiencies in -catenin"

Phrase: "trafficking in the FAD PS1 background,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   777   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C1832428:Familial form [Finding]
   757   C0277558:Familial disease [Disease or Syndrome]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:familial [Family Group]
   739   C0241888:Familial [Functional Concept]
   739   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C0599896:trafficking [Cell Function]
   739   C1418985:PS1 [Gene or Genome]
   739   C1522492:Form [Functional Concept]
   739   C1706907:Background [Conceptual Entity]
   739   C2986918:PS1 [Gene or Genome]
   722   C0237490:family background [Finding]
   722 E C0344339:disease family [Finding]

Phrase: "sufficient levels of -catenin apparently"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the nuclear compartment to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "allow for normal induction of Tcf/Lef-mediated transcription."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0040649:Transcription [Genetic Function]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205263:Induction [Functional Concept]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0683607:allow [Social Behavior]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.341: We were also able to demonstrate using the Ser353, Ser357 point mutants that disrupting the physical association between PS1 and -catenin has no impact on cell viability. 

Phrase: "We"

Phrase: "were"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Ser353,"

Phrase: "Ser357 point mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the physical association between PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "catenin"

Phrase: "has"

Phrase: "no impact on cell viability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.342: Previously, it has been proposed that FAD PS1 destabilizes -catenin, promoting a proapoptotic state (13). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that FAD PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1832428:Familial form [Finding]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "destabilizes -"

Phrase: "catenin,"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "a proapoptotic state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.343: While we observed increased susceptibility to apoptosis with expression of E280G FAD PS1 compared with wild type PS1, no further increase was seen with E280G PS1 bearing mutations at Ser353 and Ser357. 

Phrase: "While"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "increased susceptibility to apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "with expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of E280G FAD PS1"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   855   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   850   C0277558:Familial disease [Disease or Syndrome]
   814 E C0344339:family disease [Finding]
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C1832428:Familial form [Finding]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0015576:familial [Family Group]
   793   C0241888:Familial [Functional Concept]
   793   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332285:Of [Spatial Concept]
   793   C0348078:Form [Qualitative Concept]
   793   C0376315:Form [Manufactured Object]
   793   C1418985:PS1 [Gene or Genome]
   793   C1522492:Form [Functional Concept]
   793   C2986918:PS1 [Gene or Genome]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
   721 E C1704727:Family [Conceptual Entity]

Phrase: "compared with wild type PS1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "no further increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "seen with E280G PS1 bearing mutations"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0026882:Mutations [Genetic Function]
   753   C0205397:Seen [Qualitative Concept]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418985:PS1 [Gene or Genome]
   753   C1704689:Bearing [Medical Device]
   753   C2986918:PS1 [Gene or Genome]
   719 E C0004897:Bear [Mammal]
   719 E C0042789:see [Organism Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
   719 E C1947903:See [Activity]

Phrase: "at Ser353"

Phrase: "and"

Phrase: "Ser357."
Processing 00000000.tx.344: Similarly, wild type and Ser353, Ser357 mutant PS1 displayed identical responses to apoptotic insult. 

Phrase: "Similarly,"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Ser353,"

Phrase: "Ser357 mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "identical responses to apoptotic insult."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.345: Hence, we conclude that PS1/-catenin interaction is not essential for maintenance of cell survival. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that PS1/-catenin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "not essential for maintenance of cell survival."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.346: In the work of Zheng et al. 

Phrase: "In the work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "of Zheng et al."
Processing 00000000.tx.347: (13), loss of -catenin signaling was shown to increase neuronal apoptosis; 

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "loss of -catenin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1660771:neuron apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.348: however, this effect was not directly linked to -catenin instability due to FAD PS1. 

Phrase: "however,"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to -catenin instability due to FAD PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1444783:Instability [Finding]
Processing 00000000.tx.349: We suggest that the FAD PS1 effects observed on -catenin transport, stability, and cell survival signaling involve a mechanism separate from the ability of PS1 to associate with -catenin. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the FAD PS1 effects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1832428:Familial form [Finding]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "on -catenin transport,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "cell survival signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0037083:Cell Signaling [Cell Function]
           Signaling
   827   C3537152:signaling [Biologic Function]
   734   C0007620:Cell Survival [Cell Function]

Phrase: "involve"

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "separate from the ability of PS1 to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0085732:Ability [Organism Attribute]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443299:Separate [Spatial Concept]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]

Phrase: "associate with -catenin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.350: In summary, it appears that the interaction between PS1 and -catenin requires GSK-3 phosphorylation at serine residues within a consensus motif located on the PS1 loop domain. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the interaction between PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "catenin"

Phrase: "requires"

Phrase: "GSK-3 phosphorylation at serine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "within a consensus motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "located on the PS1 loop domain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2986918:PS1 [Gene or Genome]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.351: When these residues are altered to eliminate their potential for phosphorylation in vivo, binding between PS1 and -catenin is essentially abolished. 

Phrase: "When"

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "their potential for phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3245505:Potential [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "binding between PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243122:binding [Functional Concept]
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "catenin"

Phrase: "is"

Phrase: "essentially"

Phrase: "abolished."
Processing 00000000.tx.352: No negative consequences resulted from the disruption of the PS1/-catenin interaction with respect to A production, -catenin stability, Wnt signaling, or cell survival. 

Phrase: "No negative consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "resulted from the disruption of the PS1/-catenin interaction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332453:Disruption [Functional Concept]
   742   C1418985:PS1 [Gene or Genome]
   742   C1704675:Interaction [Functional Concept]
   742   C2986918:PS1 [Gene or Genome]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "with respect to A production, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "catenin stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "Wnt signaling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2984359:Wnt signaling [Functional Concept]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "or"

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.353: This indicates that association of PS1 with -catenin is nonessential for these functions and that alterations in the interaction between these two proteins are unlikely to contribute to the pathogenesis of familial Alzheimer's disease.  

Phrase: "This"

Phrase: "indicates"

Phrase: "that association of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with -catenin"

Phrase: "is"

Phrase: "nonessential for these functions"

Phrase: "and"

Phrase: "that alterations in the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "between these two proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "contribute to the pathogenesis of familial Alzheimer's disease."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0277558:Familial disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]
   744   C1880177:Contribute [Activity]
   731 E C0344339:disease family [Finding]
Processing 00000000.tx.354: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.355: Roel Nusse of Stanford University Medical Center for the Wnt-1 cDNA, Dr. 

Phrase: "Roel Nusse of Stanford University Medical Center"

Phrase: "for the Wnt-1 cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.356: Ken Kosik of Brigham and Women's Hospital and Harvard Medical School for the murine -catenin expression plasmid, and Dr. 

Phrase: "Ken Kosik of Brigham and Women's Hospital"

Phrase: "and"

Phrase: "Harvard Medical School for the murine -catenin expression plasmid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   742   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.357: Wenlin Zeng of Scios Inc. for providing the p38 kinase. 

Phrase: "Wenlin Zeng of Scios Inc."

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the p38 kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.358: We also thank Stephanie Rogers for DNA sequencing.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Stephanie Rogers for DNA sequencing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C3463939:Roger [Eukaryote]
Processing 00000000.tx.359: FOOTNOTES * This work was supported through a collaboration with Lilly.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported through a collaboration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0282116:Collaboration [Social Behavior]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "with Lilly."
Processing 00000000.tx.360: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.361: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.362: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.363: To whom correspondence should be addressed: Scios Inc., 820W.Maude Ave., Sunnyvale, CA 94086.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Scios Inc.,"

Phrase: "820W.Maude Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Sunnyvale,"

Phrase: "CA 94086.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.364: 408-616-8230; 

Phrase: "408-616-8230"

Phrase: ";"
Processing 00000000.tx.365: Fax: 408-616-8317; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "408-616-8317"

Phrase: ";"
Processing 00000000.tx.366: E-mail: cordell@sciosinc.com. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "cordell@sciosinc.com."
Processing 00000000.tx.367: Published, JBC Papers in Press, December 4,2000,DOI 10.1074/jbc.M004697200  ABBREVIATIONS The abbreviations used are: FAD, familial Alzheimer's disease; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "December 4,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M004697200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FAD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1832428:Familial form [Finding]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.368: GSK-3, glycogen synthase kinase-3; 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.369: PS1 and PS2, presenilin-1 and -2,respectively; 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2,"

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.370: CTF, C-terminal fragment; 

Phrase: "CTF,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.371: APP, -amyloid precursor protein; 

Phrase: "APP, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.372: A, -amyloid protein; 

Phrase: "A, -"

Phrase: "amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.373: APC, adenomatous polyposis coli; 

Phrase: "APC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
   717   C0162832:adenomatous polyposis coli [Gene or Genome]

Phrase: "adenomatous polyposis coli"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032580:Adenomatous Polyposis Coli [Neoplastic Process]
           Adenomatous polyposis
           Polyposis Coli
  1000   C0162832:adenomatous polyposis coli [Gene or Genome]
   827   C0334108:Polyposis [Neoplastic Process]

Phrase: ";"
Processing 00000000.tx.374: HEK, human embryonic kidney; 

Phrase: "HEK,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0086418:Human [Human]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "human embryonic kidney"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0086418:Human [Human]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.375: Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; 

Phrase: "Bis-Tris,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0053809:Bis-Tris [Organic Chemical]
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0556985:BIS [Temporal Concept]
   861   C0814229:TRI [Intellectual Product]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[bis(2-hydroxyethyl"

Phrase: ")"

Phrase: "amino"

Phrase: "]-2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(hydroxymethyl"

Phrase: ")"

Phrase: "propane-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033434:Propane [Organic Chemical]

Phrase: "3-diol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017945:diol [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.376: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.377: WT, wild type.  

Phrase: "WT, wild type."
Processing 00000000.tx.378: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.379: Cruts, M., and Van Broeckhoeven, C. 

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Van Broeckhoeven,"

Phrase: "C."
Processing 00000000.tx.380: (1998) Hum. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.381: Mutat. 

Phrase: "Mutat."
Processing 00000000.tx.382: 11, 183-190[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "11,"

Phrase: "183-190"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.383: Mattson, M. 

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: P., Guo, Q., Furukawa, K., and Pederson, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Guo,"

Phrase: "Q.,"

Phrase: "Furukawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Pederson,"

Phrase: "W."
Processing 00000000.tx.385: A. 

Phrase: "A."
Processing 00000000.tx.386: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.387: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.388: 70, 1-14[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "70,"

Phrase: "1-14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.389: Thinakaran, G. 

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.390: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.391: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.392: Invest. 

Phrase: "Invest."
Processing 00000000.tx.393: 104, 1321-1327[Free FullText] 4. 

Phrase: "104,"

Phrase: "1321-1327"

Phrase: "[Free FullText"

Phrase: "] 4."
Processing 00000000.tx.394: Price, D. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.395: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.397: (1999) Annu. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.398: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.399: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.400: 21, 479-505[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "21,"

Phrase: "479-505"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.401: Zhou, J., Liyanage, U., Medina, M., Ho, C., Simmons, A. 

Phrase: "Zhou,"

Phrase: "J.,"

Phrase: "Liyanage,"

Phrase: "U.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Simmons,"

Phrase: "A."
Processing 00000000.tx.402: D., Lovett, M., and Kosik, K. 

Phrase: "D."

Phrase: ","

Phrase: "Lovett,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.403: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.404: (1997) Neuroreport 8, 1489-1494[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroreport 8,"

Phrase: "1489-1494"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.405: Levesque, G., Yu, G., Nishimura, M., Zhang, D. 

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "D."
Processing 00000000.tx.406: M., Levesque, L., Yu, H., Xu, D., Liang, Y., Rogaeva, E., Ikeda, M., Duthie, M., Murgolo, N., Wang, L., VanderVere, P., Bayne, M. 

Phrase: "M."

Phrase: ","

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "Murgolo,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "VanderVere,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bayne,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: L., Strader, C. 

Phrase: "L., Strader,"

Phrase: "C."
Processing 00000000.tx.408: D., Rommens, J. 

Phrase: "D."

Phrase: ","

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.409: M., Fraser, P. 

Phrase: "M."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.410: E., and St. 

Phrase: "E.,"

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.411: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.412: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.413: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.414: 72, 999-1008[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "72,"

Phrase: "999-1008"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.415: Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B., and Takashima, A. 

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "S."

Phrase: ","

Phrase: "Palacino,"

Phrase: "J.,"

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.416: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.417: 433, 73-77[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "433,"

Phrase: "73-77"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.418: Yu, G., Chen, F., Levesque, G., Mishimura, M., Zhang, D.-M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., St. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "D.-"

Phrase: "M."

Phrase: ","

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.419: George-Hyslop, P., and Fraser, P. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.420: E. 

Phrase: "E."
Processing 00000000.tx.421: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.422: Biol. 

Phrase: "Biol."
Processing 00000000.tx.423: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.424: 273, 16470-16475[Abstract/Free FullText] 9. 

Phrase: "273,"

Phrase: "16470-16475"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.425: Tesco, G., Kim, T. 

Phrase: "Tesco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.426: W., Diehlmann, A., Beyreuther, K., and Tanzi, R. 

Phrase: "W., Diehlmann,"

Phrase: "A.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.427: E. 

Phrase: "E."
Processing 00000000.tx.428: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Biol. 

Phrase: "Biol."
Processing 00000000.tx.430: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.431: 273, 33909-33914[Abstract/Free FullText] 10. 

Phrase: "273,"

Phrase: "33909-33914"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.432: Saura, C. 

Phrase: "Saura,"

Phrase: "C."
Processing 00000000.tx.433: A., Tomita, T., Soriano, S., Takahashi, M., Leem, J.-Y., Honda, T., Koo, E. 

Phrase: "A.,"

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Soriano,"

Phrase: "S."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Leem,"

Phrase: "J.-Y.,"

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.434: H., Iwatsubo, T., and Thinakaran, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.435: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Biol. 

Phrase: "Biol."
Processing 00000000.tx.437: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.438: 275, 17136-17142[Abstract/Free FullText] 11. 

Phrase: "275,"

Phrase: "17136-17142"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.439: Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yanaguchi, H., Sugihara, S., and Wolozin, B. 

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kohno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yasutake,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nihonmatsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Yanaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sugihara,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.440: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.441: Natl. 

Phrase: "Natl."
Processing 00000000.tx.442: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.443: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.444: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.445: 95, 9637-9641[Abstract/Free FullText] 12. 

Phrase: "95,"

Phrase: "9637-9641"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.446: Peifer, M., and Polakis, P. 

Phrase: "Peifer,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Polakis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.447: (2000) Science 287, 1606-1609[Abstract/Free FullText] 13. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 287,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1606-1609"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.448: Zhang, Z., Hartmann, H., Do, V. 

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Hartmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Do"

Phrase: ","

Phrase: "V."
Processing 00000000.tx.449: M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., De Strooper, B., He, X., and Yankner, B. 

Phrase: "M."

Phrase: ","

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van de Wetering,"

Phrase: "M."

Phrase: ","

Phrase: "Clevers,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "He,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.450: A. 

Phrase: "A."
Processing 00000000.tx.451: (1998) Nature 395, 698-702[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "698-702"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.452: Weil, C. 

Phrase: "Weil,"

Phrase: "C."
Processing 00000000.tx.453: C., Ghadge, G. 

Phrase: "C., Ghadge,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.454: D., Kennedy, S. 

Phrase: "D."

Phrase: ","

Phrase: "Kennedy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: G., Hay, N., Miller, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440666:Hay [Immunologic Factor]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: J., and Roos, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.459: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.460: 19, 5360-5369[Abstract/Free FullText] 15. 

Phrase: "19,"

Phrase: "5360-5369"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.461: Kang, D. 

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.462: E., Soriano, S., Frosch, M. 

Phrase: "E.,"

Phrase: "Soriano,"

Phrase: "S."

Phrase: ","

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: P., Collins, T., Naruse, S., Sisodia, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: S., Leibowitz, G., Levine, F., and Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Leibowitz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Levine,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.465: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.466: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.468: 19, 4229-4237[Abstract/Free FullText] 16. 

Phrase: "19,"

Phrase: "4229-4237"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.469: Nishimura, M., Levesque, G., Zhang, D. 

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "D."
Processing 00000000.tx.470: M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., Jo, E., Supala, A., Rogaeva, E., Xu, D-M., Janus, C., Levesque, L., Bi, Q., Duthie, M., Rozmahel, R., Mattila, K., Lannfelt, L., Westaway, D., Mount, H. 

Phrase: "M."

Phrase: ","

Phrase: "Ruel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Milman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Holmes,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Kawarai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "E.,"

Phrase: "Supala,"

Phrase: "A.,"

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "D-"

Phrase: "M."

Phrase: ","

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bi,"

Phrase: "Q.,"

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "Rozmahel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mattila,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.471: T.J., Woodgett, J., Fraser, P. 

Phrase: "T.J.,"

Phrase: "Woodgett,"

Phrase: "J.,"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.472: E., and St. 

Phrase: "E.,"

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.473: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.474: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.475: Med. 

Phrase: "Med."
Processing 00000000.tx.476: 5, 164-169[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "164-169"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.477: Dong, L. 

Phrase: "Dong,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.478: Q., Zhang, R., Langlais, P., He, H., Clark, M., Zhu, L., and Liu, F. 

Phrase: "Q., Zhang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Langlais,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "He,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Clark,"

Phrase: "M."

Phrase: ","

Phrase: "Zhu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Liu,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.479: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.480: Biol. 

Phrase: "Biol."
Processing 00000000.tx.481: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.482: 274, 8117-1822[Abstract/Free FullText] 18. 

Phrase: "274,"

Phrase: "8117-1822"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.483: Thinakaran, G., Borchelt, D. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.484: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.486: H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.487: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.488: E., Jenkins, N. 

Phrase: "E.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.489: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.490: G., Price, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.491: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.492: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: (1996) Neuron 17, 181-190[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.494: Mercken, M., Takahashi, H., Honda, t., Sato, K., Murayama, M., Nakazato, Y., Noguchi, K., Imahori, K., and Takashima, A. 

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Honda,"

Phrase: "t.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Nakazato,"

Phrase: "Y.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Imahori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.495: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.496: 389, 297-303[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "389,"

Phrase: "297-303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.497: Tomita, T., Maruyama, K., Saido, T. 

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.498: C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grunberg, J., Haass, C., Iwatsubo, T., and Obata, K. 

Phrase: "C., Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.499: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.500: Natl. 

Phrase: "Natl."
Processing 00000000.tx.501: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.502: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.503: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.504: 94, 2025-2030[Abstract/Free FullText] 21. 

Phrase: "94,"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.505: Podlinsny, M. 

Phrase: "Podlinsny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Dichl, T., Levesque, G., Fraser, P., Haass, C., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Dichl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.507: H., Seubert, P., St. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.508: George-Hyslop, P., Teplow, D. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.509: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.510: J. 

Phrase: "J."
Processing 00000000.tx.511: (1997) Neurobiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.512: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.513: 3, 325-337[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "325-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.514: De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.515: (1998) Nature 391, 387-390[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 391,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "387-390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.516: Jho, E-H., Lomvardas, S., and Costantini, F. 

Phrase: "Jho,"

Phrase: "E-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lomvardas,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Costantini,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.517: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.518: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.519: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.520: Commun. 

Phrase: "Commun."
Processing 00000000.tx.521: 266, 28-35[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "266,"

Phrase: "28-35"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.522: Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Murai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Koyama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kikuchi,"

Phrase: "A."
Processing 00000000.tx.523: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.524: 17, 1371-1384[Abstract/Free FullText] 25. 

Phrase: "17,"

Phrase: "1371-1384"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.525: Sakanaka, C., Weiss, J. 

Phrase: "Sakanaka,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Weiss,"

Phrase: "J."
Processing 00000000.tx.526: B., and Williams, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Williams,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.527: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.528: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.529: Natl. 

Phrase: "Natl."
Processing 00000000.tx.530: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.531: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.532: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.533: 95, 3020-3023[Abstract/Free FullText] 26. 

Phrase: "95,"

Phrase: "3020-3023"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.534: Korinek, V., Barker, N., Morin, P. 

Phrase: "Korinek,"

Phrase: "V.,"

Phrase: "Barker,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Morin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066801:morin [Organic Chemical,Pharmacologic Substance]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.535: J., van Wichen, D., de Weger, R., Kinzler, K. 

Phrase: "J.,"

Phrase: "van Wichen,"

Phrase: "D."

Phrase: ","

Phrase: "de Weger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kinzler,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.536: W., Vogelstein, B., and Clevers, H. 

Phrase: "W., Vogelstein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Clevers,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.537: (1997) Science 275, 1784-1787[Abstract/Free FullText] 27. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1784-1787"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.538: Morin, P. 

Phrase: "Morin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066801:morin [Organic Chemical,Pharmacologic Substance]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.539: J., Sparks, A. 

Phrase: "J.,"

Phrase: "Sparks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883069:SPARK [Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.540: B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Korinek,"

Phrase: "V.,"

Phrase: "Barker,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Clevers,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vogelstein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Kinzler,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.541: W. 

Phrase: "W."
Processing 00000000.tx.542: (1997) Science 275, 1787-1790[Abstract/Free FullText] 28. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1787-1790"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.543: Fiol, C. 

Phrase: "Fiol,"

Phrase: "C."
Processing 00000000.tx.544: J., Wang, A., Roeske, R. 

Phrase: "J.,"

Phrase: "Wang,"

Phrase: "A.,"

Phrase: "Roeske,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.545: W., and Roach, P. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Roach,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.546: J. 

Phrase: "J."
Processing 00000000.tx.547: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.548: Biol. 

Phrase: "Biol."
Processing 00000000.tx.549: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.550: 265, 6061-6065[Abstract/Free FullText] 29. 

Phrase: "265,"

Phrase: "6061-6065"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.551: Seger, M., Nordstedt, C., Petanceska, S., Kovacs, D. 

Phrase: "Seger,"

Phrase: "M."

Phrase: ","

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Petanceska,"

Phrase: "S."

Phrase: ","

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.552: M., Gouras, G. 

Phrase: "M."

Phrase: ","

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.553: K., Hahne, S., Fraser, P., Levesque, G., Czernik, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hahne,"

Phrase: "S."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Czernik,"

Phrase: "A."
Processing 00000000.tx.554: J., St. 

Phrase: "J.,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.555: George-Hyslop, P., Sisodia, S. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.556: S., Thinakaran, G., Tanzi, R. 

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: E., Greengard, P., and Gandy, S. 

Phrase: "E.,"

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.558: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.559: Natl. 

Phrase: "Natl."
Processing 00000000.tx.560: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.561: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.562: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.563: 94, 5090-5094[Abstract/Free FullText] 30. 

Phrase: "94,"

Phrase: "5090-5094"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.564: Walter, J., Grunberg, J., Capell, A., Pesold, B., Schindzielorz, A., Citron, M., Mendla, K., St. 

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schindzielorz,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Mendla,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.565: George-Hyslop, P., Multhaup, G., Selkoe, D., and Haass, C. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.566: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.567: Natl. 

Phrase: "Natl."
Processing 00000000.tx.568: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.569: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.570: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.571: 94, 5349-5354[Abstract/Free FullText] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "94,"

Phrase: "5349-5354"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

